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A B S T R A C T
Background
The prevalence of chronic heart failure is increasing, and increases with increasing age. Major symptoms include breathlessness and
restricted activities of daily living due to reduced functional capacity, which in turn affects quality of life. Exercise training has been
shown to be effective in patients with coronary heart disease and has been proposed as an intervention to improve exercise tolerance in
patients with heart failure.
Objectives
To determine the effectiveness of exercise based interventions compared with usual medical care on the mortality, morbidity, exercise
capacity and health related quality of life, of patients with heart failure.
Search strategy
We searched the Cochrane Controlled Trials Register (The Cochrane Library Issue 2, 2001), MEDLINE (2000 to March 2001),
EMBASE (1998 to March 2001), CINAHL (1984 to March 2001) and reference lists of articles. We also sought advice from experts.
Selection criteria
RCTs of exercise based interventions. The comparison group was usual medical care as defined by the study, or placebo. Adults of all
ages with chronic heart failure. Only those studies with criteria for diagnosis of heart failure (based on clinical findings or objective
indices) have been included.
Data collection and analysis
Studies were selected, and data were abstracted, independently by two reviewers. Authors were contacted where possible to obtain
missing information.
Main results
Twenty-nine studies met the inclusion criteria, with 1126 patients randomised. The majority of studies included both patients with
primary and secondary heart failure, NYHA class II or III. Only one study specifically examined the effect of exercise training on
mortality and morbidity. Exercise training significantly increased VO2 max by (WMD random effects model) 2.16 ml/kg/min (95%
CI 2.82 to 1.49), exercise duration increased by 2.38 minutes (95% CI 2.85 to 1.9), work capacity by 15.1 Watts (95% CI 17.7 to
1Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
12.6) and distance on the six minute walk by 40.9 metres (95% CI 64.7 to 17.1). Improvements in VO2 max were greater for training
programmes of greater intensity and duration. HRQoL improved in the seven of nine trials that measured this outcome.
Authors’ conclusions
Exercise training improves exercise capacity and quality of life in patients mild to moderate heart failure in the short term. One study
found beneficial effects of exercise on cardiac mortality and hospital readmissions over 3 years of follow-up, the remaining included
studies did not aim to measure clinical outcomes and were of short duration. The findings of the review are based on small-scale trials in
patients who are unrepresentative of the total population of patients with heart failure. Other groups (more severe patients, the elderly,
women) may also benefit. Large-scale pragmatic trials of exercise training of longer duration, recruiting a wider spectrum of patients
are needed to address these issues.
P L A I N L A N G U A G E S U M M A R Y
Exercise training improves exercise tolerance and quality of life in people with mild to moderate heart failure
People with heart failure experience breathlessness and restricted activities of daily living because of their restricted heart capacity. This
can reduce their amount of exercise, which can further reduce fitness, making their symptoms worse. The review found short-term
trials of exercise training in people with mild to moderate heart failure only, which do not represent most of the people who have
heart failure. The kinds of exercise programs varied greatly, but most included aerobic exercise rather than resistance training (such as
working with weights). Exercise improved people’s fitness and quality of life, without causing harm.
B A C K G R O U N D
The prevalence and incidence of chronic heart failure (CHF) is
steadily increasing with approximately 550,000 new cases annu-
ally in the United States (AHA). Whilst improved management
of hypertension has reduced this condition as an aetiological fac-
tor in the development of heart failure, the increased survival rate
frommyocardial infarction has lead to a subsequent increase in the
number of cases of chronic heart failure (Kostis 1997), as has in-
creasing longevity in developed countries. In the developing world
the occurrence of heart failure can often be attributed to valvular
heart disease and nutritional cardiac disease (Lip 2000). Estimates
of the prevalence of heart failure in Europe range from 0.4 to 2%
in middle aged adults (Cowie 1997), but over 65 years of age the
prevalence of CHF is in the region of 6 to 10%. (Kannel 1991).
Hospital admission rates for heart failure are rising in all industri-
alised countries, particularly among the elderly (McMurray 2000).
Patients with heart failure present with a variety of symptoms
most of which are often non specific (Watson 2000). The most
frequently presenting symptom is exertional breathlessness. Addi-
tional important symptoms may be fatigue and lethargy, in addi-
tion to swelling of the feet and ankles. Symptoms and functional
exercise capacity are used to classify the severity of heart failure
(using the New York Heart Association (NYHA) classification)
and judge the response to treatment. Whilst the classification of
severity is based upon symptoms, the diagnosis is secured with
objective measures. The European Task Force report (CHF Task-
force 2001) proposes that the definition of heart failure should
rely on two criteria: symptoms of heart failure at rest or during ex-
ercise (typically breathlessness and fatigue) and objective evidence
of cardiac dysfunction at rest. Where the diagnosis is in doubt, a
response to treatment directed towards heart failure may also be
used in addition to the above criteria. However, like many chronic
diseases there is a poor correlation between symptoms and the de-
gree of cardiac impairment, and also between symptoms and dis-
ease prognosis ( Hülsmann 2002; Opasich 2001; van den Brock
1992).
Coupled with the pathological changes of heart failure and associ-
ated symptoms is a reduction in exercise tolerance due to impaired
skeletal muscle function. Muscle function depends upon perfu-
sion, muscle mass, fibre composition and energy metabolism - al-
teration of any of these will influence physical performance. Mus-
cle performance can be defined as either strength or endurance and
both can be reduced in chronic heart failure. For heart failure there
is reduced capillary fibre ratio, reduced peripheral blood flow and
an alteration in mitochondrial density, leading to a reduced ox-
idative capacity of the peripheral muscle (Drexler 1992; Mancini
1992; Sullivan 1989). Inactivity contributes to these changes. De-
creased exercise capacity restricts activities of daily living, this in
2Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
turn influences an individual’s independence and quality of life.
The management of chronic heart failure is characterised by a
combination of drugs and lifestyle changes. Drug therapy aims
to control symptoms by controlling fluid balance and blocking
neurohormonal activation. Lifestyle management is important in
chronic heart failure and includes diet and exercise. Decreased ex-
ercise capacity is the main factor restricting daily activity for this
patient group. Patients become trapped in a vicious circle of in-
activity and decreasing functional capacity. Historically patients
with heart failure were advised to avoid exertion for fear of wors-
ening cardiac function due to myocardial stress. In the late 1970s
and early 1980s it was reported that exercise training was safe
in patients with impaired ventricular function. These studies re-
ported a significant improvement in work capacity after training
(Conn 1982; Lee 1979). In 1990 Coats and colleagues demon-
strated a beneficial effect of exercise training on exercise tolerance,
peak oxygen consumption and symptoms in a cross over trial of
patients with heart failure, and concluded that rest as the mainstay
of treatment for chronic heart failure should no longer be accepted
(Coats 1990). This has been confirmed in a number of trials sub-
sequently (e.g. Keteyian 1996; Kiilavuori 1996, ). More recently
studies have focused on the central and peripheral physiological
changes after precisely prescribed exercise regimens. The positive
effects of exercise training are thought to occur mainly peripher-
ally in skeletal muscle. These include reduced lactate production
(delayed onset of anaerobic metabolism), improved aerobic ca-
pacity, reduced sympathetic drive and increased vagal tone (Belar-
dinelli 1992; Coats 1992; Hambrecht 1995; Tyni-Lenne/Gordon
96). Ventilatory parameters also improve. Changes in peak oxy-
gen consumption are consistently documented as are improved
anaerobic threshold and decreases in the ventilatory equivalent for
carbon dioxide (Tyni-Lenne 2001; Wielenga 1999 CHANGE).
Some central cardio-vascular changes have been reported such as
improvedmyocardial perfusion (Belardinelli 1999), improved car-
diac output at sub-maximal work rates (Coats 1992), associated
reduction in peak heart rates (Keteyian 1996) and improved pe-
ripheral blood flow (Dziekan 1998; Sullivan 1988).
The effectiveness of exercise based rehabilitation in patients with
coronary heart disease (CHD) has been demonstrated in two early
meta-analyses (Oldridge 1988; O’Connor 1989), and in an up-
dated recent Cochrane systematic review (Jolliffe 2001). These
systematic reviews specifically excluded patients with heart failure.
Exercise based rehabilitation significantly reduces all cause and car-
diac mortality, cholesterol and cigarette smoking in patients with
CHD (Jolliffe 2001). The provision of cardiac rehabilitation for
patients with CHD in the UK is required by recent policy (Na-
tional Service Framework for Coronary Heart disease - Standard
12, DOH 2000). It is suggested that cardiac rehabilitation should
also be considered as an option for patients with heart failure who
may potentially benefit (Standard 11, DOH 2000). Currently, pa-
tients with heart failure are underrepresented in cardiac rehabili-
tation programmes (NHS 1998).
The current review in a series on cardiac rehabilitation (Jolliffe
2001; Rees 2004) will concentrate on exercise based interventions
for heart failure. The effectiveness of exercise based rehabilitation
for patients with heart failure has been examined in a recent quali-
tative overview where the authors found beneficial effects on phys-
ical performance in 27 of 31 studies identified, onmortality in 1 of
31 studies, and of quality of life in 1 of 16 studies (Lloyd-Williams
2002). Whilst this review was comprehensive in its search strategy
in that many data sources were searched, it did exclude non-En-
glish language publications, it included non randomised and be-
fore and after studies (only 22 of 31 studies were randomised con-
trolled trials), and made no attempt to pool data statistically from
those trials which were identified. Thus no estimate of effect size
for exercise interventions for CHF patients was obtained for any
outcome examined. Furthermore, several randomised controlled
trials have been published which were not included in the above
review.
O B J E C T I V E S
Todetermine the effectiveness of exercise based interventions com-
pared with usual medical care on themortality, morbidity, exercise
capacity and health related quality of life, of patients with heart
failure. A secondary objective was to examine any adverse events
associated with exercise in these patients.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials either a parallel group or cross-over
design.
Types of participants
All adults with chronic heart failure. Only those studies with cri-
teria for diagnosis of heart failure (based on clinical findings or
objective indices) have been included. Where possible we have
distinguished between patients with primary heart failure (dilated
cardiomyopathy - DCM), and those with heart failure secondary
to coronary heart disease (CHD). Studies including patients who
have previously been offered cardiac rehabilitation for either my-
ocardial infarction or heart failure have been excluded.
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Types of interventions
Exercise based interventions, either alone or as a component of
comprehensive cardiac rehabilitation (defined as programmes in-
cluding also other components such as health education and psy-
chological interventions, in addition to exercise interventions).
The comparison group was usual medical care as defined by the
study, or an “attention placebo”.
Types of outcome measures
(1) All cause mortality;
(2)Morbidity - non-fatal myocardial infarction, revascularisation;
(3) Hospital admissions/re-hospitalisation;
(4) Exercise capacity;
(5) Physical activity levels;
(6) Validated measures of health related quality of life (HRQoL).
Search methods for identification of studies
We searched the Cochrane Controlled Trials Register (The
Cochrane Library Issue 2, 2001) using the strategy outlined be-
low. This was updated by searching MEDLINE (2000 to March
2001) on Ovid using a standard RCT filter (Dickersin 1994) and
EMBASE (1998 to March 2001) using an EMBASE RCT filter
(Lefebvre 1996) and searching CINAHL (1984 to March 2001).
In addition, we searched reference lists of articles and sought ex-
pert advice. No language restrictions were applied.
CCTR Search Strategy
1. HEART-FAILURE-CONGESTIVE*:ME
2. (HEART and FAILURE)
3. (CARDIAC and FAILURE)
4. ((#1 or #2) or #3)
5. REHABILITATION*:ME
6. EXERCISE*:ME
7. EXERCISE-THERAPY*:ME
8. SPORTS*:ME
9. PHYSICAL-EDUCATION-AND-TRAINING*:ME
10. EXERTION*:ME
11. REHABILITAT*
12. (PHYSICAL* near FIT)
13. (PHYSICAL* near FITNESS)
14. (PHYSICAL near TRAIN*)
15. (PHYSICAL* near ACTIVIT*)
16. (TRAIN* near STRENGTH*)
17. (TRAIN* near AEROBIC*)
18. (AEROBIC* near EXERCISE*)
19. KINESIOTHERAP*
20. (EXERCISE* near TRAIN*)
21. (((((((((((((((#5 or #6) or #7) or #8) or #9) or #10) or #11) or
#12) or #13) or #14) or #15) or #16) or #17) or #18) or #19) or
#20)
22. (#4 and #21)
Data collection and analysis
Study selection
From the searches, the title and abstract of each paper was reviewed
by one reviewer (KR) and potentially relevant references retrieved.
Following this initial screening, two reviewers (KR, RT) indepen-
dently selected trials to be included in this review using prede-
termined inclusion criteria. In all cases disagreements about any
study inclusions were resolved by consensus. The general agree-
ment for two raters over all categories (study included, excluded
or pending) was assessed by Cohen’s kappa (weighted). Observed
agreement was 88.3%, expected agreement 54%, Kappa = 0.75
(95% confidence interval = 0.57 to 0.93). The quality of trials was
assessed in terms of concealment of allocation, losses to follow up,
and blind assessment of outcomes. Quality was also assessed by
using the Jadad Scale (Jadad 1996).
Data extraction
Study outcome data were extracted by one reviewer (KR) and
chief investigators were contacted to provide additional relevant
information. Data extraction was checked by a second reviewer
(RT) in a random sample of 10 studies.
Data analysis
Dichotomous outcomes were expressed as odds ratios, and 95%
confidence intervals (CI) were calculated for each study. For con-
tinuous variables net changes were compared (i.e. control group
minus intervention group differences) and a weighted mean dif-
ference (WMD) or standardised mean difference (SMD) and 95%
CI have been calculated for each study. Where standard deviation
differences were not reported in the source papers, allowance has
been made for within patient correlation from baseline to follow
up measurements by using the correlation coefficient between the
two (Cochrane Heart Group; Follmann 1992).
For cross-over trials, data from the first arm only has been in-
cluded. Where data for the two arms is combined then this has
been accepted only if the authors state there are no carryover ef-
fects, or there is evidence of washout.
For each outcome, a test of heterogeneity was carried out. In the
situation of no heterogeneity, fixed effects meta-analysis was used.
If substantial heterogeneity (p<0.1) was detected, the reviewers
looked for possible explanations (e.g. participants and interven-
tion) for this. If the heterogeneity could not be explained, the
reviewers considered the following options: not to aggregate the
studies at all, or use a random effects model with appropriate cau-
tious interpretation. Where a random effects model has been used
this is indicated in parentheses.
Stratified analyses and meta-regression were used to examine the
effect of intensity of the intervention, age, duration of follow up
and trial quality on the outcome VO2 max, the outcome most
frequently reported in the included studies. These subgroups were
defined in advance. Sensitivity analysis was carried out to examine
the effect of excluding the few studies which did not include an
aerobic training component.
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R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
From the searching, 1162 studies were found, the title and ab-
stracts of these were screened and 79 went forward for formal in-
clusion or exclusion. Thirty three separate trials met the inclusion
criteria. Of these, 4 were later excluded; 3 because of insufficient
data despite contacting the authors to obtain information, and
one because of overlap in the participants recruited in another in-
cluded study. Data from the remaining 29 studies with 1126 pa-
tients randomised were used in the analyses. Of these 29 trials, 23
evaluate an aerobic intervention and 6 report resistance training
of peripheral muscle groups. Twenty three of the trials are parallel
group design, the remaining 6 are cross over trials. The majority
of trials include both patients with primary (dilated cardiomy-
opathy) and secondary (ischemic heart disease) heart failure, with
only 4 trials reporting these patient groups separately. All patients
included met the New York Heart Association (NYHA) criteria
for symptoms (class II or III) and all had a left ventricular ejec-
tion fraction (LVEF) < 40%. The mean age of participants across
the included studies ranged from 51 to 77 years. Most studies
recruited predominantly male patients with the exception of two
studies that recruited only women (Pu 2001; Tyni-Lenne 1997).
Mean follow up was 20 (SD 14) weeks (range 4 to 60 weeks) for
exercise variables and quality of life. One study reported clinical
data at 3.3 years of follow-up (Belardinelli 1999).
Details of the studies included in the review are shown in the
table ’Characteristics of included studies’. Reasons for exclusion
are presented in the table ’Characteristics of excluded studies’.
Risk of bias in included studies
The methodological quality of the included studies are presented
in Table 01. The methodological quality of trials in terms of the
method of randomisation, allocation concealment, blinding of
outcome assessors and losses to follow up, is as was reported in the
papers. For the majority of studies, both the method of randomi-
sation, and the method of allocation concealment were unclear.
Most of the trials were short term studies and so therefore the loss
to follow up was low, with the exception of five trials where this
was greater than 20%. Themedian Jadad score for the 34 trials was
2 (interquartile range 2 to 3, range 1 to 4), out of a possible score
of 5 (Jadad 1996). The Jadad score has been used as an overall
indicator of trial quality in the stratified analyses to examine its
impact on outcome (see results section).
Effects of interventions
Clinical events
Only one study with long term follow-up aimed to examine the
effect of exercise on mortality and morbidity (Belardinelli 1999).
This study showed that cardiac mortality was statistically signifi-
cantly reduced with the exercise intervention over 3.3 years of fol-
low-up (99 patients randomised, odds ratio 0.32 (95% CI 0.13,
0.8)), as were hospital readmissions for heart failure (odds ratio
0.28 (95% CI 0.09, 0.85)). There was no statistically significant
effect of the intervention on non-fatal myocardial infarction (odds
ratio 0.48 (95% CI 0.04, 5.47)).
Several studies report deaths as dropouts during the study period,
which the authors state were unrelated to the intervention (Got-
tlieb 1999;Hambrecht 1995;Hambrecht 1998;Hambrecht 2000;
Owen 2000; Ponikowski 1997; Teo 1995 EXERT;Wielenga 1999
CHANGE). Nonetheless, if we pool this data for all cause mor-
tality there is no significant difference between the intervention
and control groups (odds ratio 1.12 (95% CI 0.58 to 2.15)). The
follow-up period for these trials ranged from 16 to 52 weeks. One
study reported a non-fatal MI in the control group (Ponikowski
1997), none of the studies report other clinical events.
Adverse events
Whilst not a primary objective of the review, all studies were ex-
amined for reports of any adverse events during exercise training.
Adverse events were those as defined by the authors, and/or clin-
ical events (including deaths, myocardial infarction, arrhythmias)
reported to be associated with exercise training. The majority of
studies state that there were no adverse events associated with the
intervention (17 of 29 studies), although these studies were not
designed to examine safety, nor did they state in their objectives
that they would do so. Only one trial reported complications as-
sociated with training, but these were confined to the most severe
patients with ejection fractions below 30% (Jette 1991).
Exercise variables
For all variables concerned with exercise capacity, an increase in
value from baseline to follow-up indicates improvement with the
exercise intervention. For this reason, the sign of the mean change
in these variables for both the intervention and control groups has
been changed for the pooled analysis so the direction of effect is
in the appropriate direction on the Metaview plots.
VO2 max was measured in 24 studies (848 participants ran-
domised) and improved markedly with exercise training by 2.16
ml/kg/min (WMD random effects model, 95% CI 2.82 to 1.49).
Similar significant improvements were seen for exercise duration
measured in 15 studies (510 participants randomised) which in-
creased by 2.38 minutes (WMD 95%CI 2.85 to 1.92), and maxi-
mum work capacity measured in six studies (219 participants ran-
domised) which increased by 15.1 Watts (WMD 95% CI 17.7 to
12.6) in the training group. Distance on the six minute walk was
measured in eight studies (282 participants randomised) which
increased by 40.9 metres (WMD random effects model 95% CI
64.7 to 17.1). Heterogeneity between studies for this outcome is
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due to one trial (Teo 1995 EXERT) that showed no effect of in-
tervention, whilst the remaining seven showed large positive ef-
fects. This trial measured outcomes over the short (3 months) and
longer term (12 months) and results were similar for both time
periods.
Subgroup analyses
Marked heterogeneity was seen for the outcome VO2 max (chi
square 61.27, p < 0.00001), and to explore this further we carried
out a number of prespecified subgroup analyses. The cut-off points
used for each explanatory variable were the median values for the
studies reporting this outcome.
The variables thought to have an impact on heterogeneity between
studies included
• the intensity of the intervention (“Dose” calculated as the
number of weeks multiplied by the number of sessions per week,
multiplied by the duration of sessions in hours);
• duration of the intervention;
• trial quality assessed by the Jadad score (determined from
what was reported in the papers);
• duration of follow-up and
• mean age.
The “dose” of the intervention varied from 3 to 112 units (mean
40.3 SD 30.7), and the duration of the intervention varied from
3 to 52 weeks (mean 16 SD 11.5) across the studies.
Interventions of greater intensity had a larger effect on the im-
provements seen in VO2 max but the 95% CI’s overlapped with
lower doses suggesting that the difference between the two was not
statistically significant (Dose > 30 units WMD, random effects
model 2.78 (95% CI 3.88 to 1.69)), Dose < 30 units WMD 1.64
(95% CI 2.2 to 1.1). Slightly larger effects on VO2 max were seen
with studies of poorer methodological quality (Jadad score 2 and
below), but this was not statistically significant. The improvement
in VO2 max was greater in patients aged less than 55 years WMD
2.95 (95% CI 4.25 to 1.64) versus greater than 55 years WMD
1.77 (95% CI 2.5 to 1.03), but again this does not reach statistical
significance. Age is reported in all studies as an aggregate mea-
sure and thus comparison between these two age groups may be
misleading as individual patient data are not available to examine
effects across the whole age range. The effect size increased with
increasing duration of follow-up, but this is a marker also for the
duration of the intervention since most studies were short term
with follow-up assessment at or shortly following the end of the
intervention.
Meta regression
Heterogeneity for the outcome VO2 max was also examined with
meta-regression. Covariates defined a priori included trial qual-
ity, dose of intervention, duration of intervention and length of
follow-up. In univariate analyses, the Jadad score had no effect
on the level of VO2 max achieved at the end of exercise training.
Statistically significant associations were seen with dose of inter-
vention, duration of intervention and duration of follow-up. In
multivariate analyses both the dose of the intervention and the
duration of follow-up contributed to the heterogeneity of VO2
max, where the weightedmean difference (WMD) for VO2 max is
multiplied by a factor of 1.01 per unit increase in dose (coefficient
log WMD 0.0137 95% CI 0.0019 to 0.025 p=0.023), and the
weighted mean difference for VO2 max is multiplied by a factor
of 1.03 per week increase in follow-up duration (coefficient log
WMD 0.0302 95% CI 0.013, 0.046 p<0.001). Thus the level of
VO2 max at the end of exercise training increases with increasing
dose of the intervention, and increasing follow-up period. As noted
above, since most studies were short term studies, the follow-up
period is a marker for exercise duration, which is also included in
the estimate of dose.
Sensitivity analyses
Themajority of studies include an aerobic exercise component. To
determine the impact of aerobic exercise alone, sensitivity analyses
were carried out excluding studies which focused exclusively on
resistance training. This had no significant effect on the pooled
analysis for the outcomes VO2 max or distance on the 6 minute
walk.
Health related quality of life
The number of different scales used to assess HRQoL, and the
different intervention groups (both aerobic and resistance train-
ing), as well as the relatively few trials that reported this as an out-
come, meant that a pooled analysis was inappropriate. Data has
been presented qualitatively in Table 02. Nine of 29 trials reported
HRQoL as an outcome. Seven out of nine studies found improve-
ments in HRQoL in the intervention group compared to control.
Five studies used the disease specific measure the Minnesota Liv-
ing with Heart Failure questionnaire (Belardinelli 1999; Parnell
2002; Ponikowski 1997; Teo 1995 EXERT; Tyni-Lenne 2001)
where significant improvements were seen for 4/5 studies over the
short term. Two of these 5 studies measured quality of life over the
longer term of 12 months, one showed improvement was main-
tained over the long term (Belardinelli 1999), the other showed
no difference between intervention and control groups, as for the
shorter term assessment (Teo 1995 EXERT). Other scales used
included theMOS Short Form (SF) 36, CHF questionnaire, Sick-
ness Impact Profile (SIP) and Nottingham Health Profile (NHP)
parts 1 and 2.
D I S C U S S I O N
This is the most comprehensive systematic review to date to ex-
amine the effectiveness of exercise training for heart failure. How-
ever, the trials identified for inclusion were mostly small and of
relatively poor methodological quality, recruitingmostly men, and
patients with stable chronic heart failure. Patients with severe dis-
ease and co-morbidities were often excluded. The findings there-
fore are confined to this particular group of patients and may not
be generalisable to all patients with heart failure.
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Highly statistically significant improvements in exercise capacity
were found as assessed by maximum oxygen uptake, exercise du-
ration, distance on the 6 minute walk and physical work capacity.
These improvements in intermediate outcomes confirm previous
findings (Lloyd-Williams 2002). As most trials are of relatively
short duration, it is unclear whether these improvements are sus-
tained. Indeed, conflicting results were found for the two largest
trials monitoring the effects of exercise training over 12 months
where sustained improvement in functional capacity was found in
one trial (Belardinelli 1999), and no effect of exercise training was
found in the other (Teo 1995 EXERT).
One of our principal objectives was to determine the effect of ex-
ercise training on clinical outcomes. Only one trial with a long
follow-up period examined the effect of exercise training on mor-
tality and morbidity, where favorable outcomes were seen for car-
diac mortality and hospital readmissions (Belardinelli 1999). The
authors of this trial state that the patients who died had a higher
resting heart rate, end-diastolic diameter and wall thickening score
index, and lower systolic blood pressure and VO2 max at peak ex-
ercise than those patients who survived. Other studies did report
clinical events as reasons for loss to follow-up, but the majority of
these (7/8 trials) were short term studies. Pooling this data for the
8 of 29 trials reporting all cause mortality showed no evidence of
effect of exercise training on this outcome. Further longer term
trials are needed to examine the effect of exercise training on clin-
ical outcomes. Several trials are currently underway and we await
the results with interest. The Exercise Intervention Strategies in
Heart Failure Trial (EXIST) is a multicentre trial designed to ex-
amine the effect of exercise training on morbidity and mortality in
heart failure patients (NRR ongoing trial 1). The trial was due to
be completed in December 2002. Another trial, due to complete
in January 2004 looks specifically at elderly patients with heart
failure and whether long term provision of exercise training can
improve mortality and morbidity (NRR ongoing trial 2).
Whilst it was not our primary aim to examine adverse events, it is
noteworthy that only one of 29 trials reported complications asso-
ciated with training, and in the most severe patients (Jette 1991).
As most of the trials are conducted in patients with stable chronic
heart failure with NYHA functional class II or III, perhaps this is
not unexpected. Concerns about safety have historically been the
reason for exclusion of heart failure patients from exercise training
and cardiac rehabilitation programmes. Today, it is now generally
accepted that exercise training is safe in patients with stable heart
failure, but that there is as yet no trial evidence to recommend
exercise training in unstable heart failure or those with NYHA
class IV (CHF Guidelines 2001). We were unable to examine the
effects of exercise training separately for those patients with di-
lated cardiomyopathy and those with heart failure secondary to
coronary heart disease as most trials recruited a mix of these pa-
tients, the majority being those in the latter group. Similarly we
were unable to examine the effects of gender or age on outcome.
Lack of research evidence in these groups may result in exclusion
of women and the elderly from training programmes.
Relatively few trials examined health related quality of life. Of
those that used validated scales to assess this, many different in-
struments were used over different time periods which meant that
pooling data statistically was inappropriate. Most of the studies
that measured this outcome (7 of 9 studies) showed beneficial ef-
fects of exercise training. As for the exercise variables above, the
2 trials which measured quality of life over the long term (12
months) had conflicting results (Belardinelli 1999; Teo 1995 EX-
ERT). More large scale trials of longer duration are needed to re-
solve these discrepancies. The publication of the two longer term
ongoing trials cited above (NRR ongoing trial 1, NRR ongoing
trial 2) will add to the existing evidence and may help resolve these
issues.
The exercise intervention varied in mode, intensity and duration
between studies. The current guidelines for exercise training in
heart failure acknowledge the benefits of aerobic training but that
the precise protocol is yet to be established and should be indi-
vidually tailored to baseline clinical and functional status. Rela-
tively little attention has been paid to resistance training, and it is
not generally recommended until further data are available (CHF
Guidelines 2001). Most of the studies included in this review ex-
amined aerobic training. Exclusion of the few studies which fo-
cused exclusively on resistance training had no effect on functional
outcomes. The outcome VO2 max was most frequently reported
and showed large heterogeneity between studies. To try to explain
this and examine the impact of different levels of exercise on VO2
max, we performed metaregression. The dose of the intervention
(the product of exercise duration, number of sessions and dura-
tion of training period) explained much of the variation, with im-
provements in VO2 max seen for increasing “doses” of exercise
training. This finding is important and with the advent of longer
term studies, the longer term effects of different training periods
can be established.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review shows that exercise training improves exercise capac-
ity and HRQoL in patients with NYHA functional status class
II or III heart failure. However, further work is necessary to in-
form clinical guideline development. At present exercise training is
only recommended in those patients with stable heart failure and
NYHA functional class II or III, and only aerobic exercise train-
ing is recommended in a supervised hospital based setting, each
protocol being tailored to individual needs. Whilst each patient
must be treated as an individual, some broad protocols informed
by research would help in clinical practice. Due to lack of research
there is little evidence of benefit in certain groups (more severe
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patients, elderly people, women) who may then subsequently be
omitted from programmes. The trial evidence to date is unlikely
to represent the majority of patients with heart failure.
Implications for research
The findings are based on small trials in patients who are unrep-
resentative of the total population of patients with heart failure.
The effectiveness of exercise training on functional capacity and
quality of life is clear in the short term but is unknown in the
longer term. Large, long-term pragmatic trials of exercise training
are needed to determine the effectiveness of exercise training on
morbidity, quality of life, and mortality. The value of continued
exercise training for maintenance of benefit also requires evalua-
tion.
A C K N OW L E D G E M E N T S
Wewould like to acknowledge the following authors for providing
us with additional data, A Maiorana, A Gordon.
We would like to acknowledge Dr Andrea Conti and Dr Jan
Melichar for translations.
R E F E R E N C E S
References to studies included in this review
Belardinelli 1992 {published data only}
Belardinelli R, Scocco V, Mazzanti M, et al.Effects of
aerobic training in patients with moderate chronic heart
failure. Giornale italiano di cardiologia 1992;22(8):919–30.
Belardinelli 1995 {published data only}
Belardinelli R, Georgiou D, Cianci G, Berman N, Ginzton
L, Purcaro A. Exercise training improves left ventricular
diastolic filling in patients with dilated cardiomyopathy.
Clinical and prognostic implications. Circulation 1995;91
(11):2775–84.
Belardinelli 1999 {published data only}
Belardinelli R, Georgiou D, Cianci G, Purcaro A.
Randomized, controlled trial of long-term moderate exercise
training in chronic heart failure: effects on functional
capacity, quality of life, and clinical outcome. Circulation
1999;99(9):1173–82.
Cider 1997 {published data only}
Cider A, TygessonH,HedbergM, Seligman L,Wennerblom
B, Sunnerhagen KS. Peripheral muscle training in patients
with clinical signs of heart failure. Scandinavian Journal of
Rehabilitation Medicine 1997;29(2):121–7.
Coats 1990 {published data only}
Coats A, Adamopoulos S. A cross-over comparison of
outpatient physical training versus rest in the treatment of
moderate to severe heart failure [abstract]. Clinical Science
1989;77(Suppl 21):19P.
Coats AJ, Adamopoulos S, Meyer TE, Conway J, Sleight P.
Effects of physical training in chronic heart failure. Lancet
1990;335(8681):63–6.
Coats 1992 {published data only}
Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer
TE, Bernardi L, et al.Controlled trial of physical training in
chronic heart failure. Exercise performance, hemodynamics,
ventilation, and autonomic function. Circulation 1992;85
(6):2119–31.
Dubach et al studies {published data only}
Callaerts-Vegh Z, Wenk M, Goebbels U, Dziekan G, Myers
J, Dubach P, et al.Influence of intensive physical training
on urinary nitrate elimination and plasma endothelin-1
levels in patients with congestive heart failure. Journal of
Cardiopulmonary Rehabilitation 1998;18(6):450–7.
Dubach P, Myers J, Dziekan G, Goebbels U, Reinhart W,
Muller P, et al.Effect of high intensity exercise training on
central hemodynamic responses to exercise in men with
reduced left ventricular function. Journal of the American
College of Cardiology 1997;29(7):1591–8.
Duru F, Candinas R, Dziekan G, Goebbels U, Myers J,
Dubach P. Effect of exercise training on heart rate variability
in patients with new-onset left ventricular dysfunction after
myocardial infarction. American Heart Journal 2000;140
(1):157–61.
Dziekan G, Myers J, Goebbels U, Muller P, Reinhart W,
Ratti R, et al.Effects of exercise training on limb blood flow
in patients with reduced ventricular function. American
Heart Journal 1998;136(1):22–30.
Goebbels U, Myers J, Dziekan G, Muller P, Kuhn M, Ratte
R, et al.A randomized comparison of exercise training in
patients with normal vs reduced ventricular function. Chest
1998;113(5):1387–93.
Myers J, Gianrossi R, Schwitter J, Wagner D, Dubach P.
Effect of exercise training on postexercise oxygen uptake
kinetics in patients with reduced ventricular function. Chest
2001;120(4):1206–11.
Myers J, Goebbels U, Dzeikan G, Froelicher V, Bremerich J,
Mueller P, et al.Exercise training and myocardial remodeling
in patients with reduced ventricular function: One-year
follow-up with magnetic resonance imaging. American
Heart Journal 2000;139(21):252–61.
Gottlieb 1999 {published data only}
Gottlieb SS, Fisher ML, Freudenberger R, Robinson S,
Zietowski G, Alves L, et al.Effects of exercise training on
peak performance and quality of life in congestive heart
failure patients. Journal of Cardiac Failure 1999;5(3):
188–94.
8Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hambrecht 1995 {published data only}
Hambrecht R, Niebauer J, Fiehn E, Kalberer B, Offner
B, Hauer K, et al.Physical training in patients with stable
chronic heart failure: effects on cardiorespiratory fitness and
ultrastructural abnormalities of leg muscles. Journal of the
American College of Cardiology 1995;25(6):1239–49.
Hambrecht 1998 {published data only}
Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C,
Kaiser R, et al.Regular physical exercise corrects endothelial
dysfunction and improves exercise capacity in patients with
chronic heart failure. Circulation 1998;98(24):2709–15.
Hambrecht 2000 {published data only}
Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther
C, et al.Effects of exercise training on left ventricular
function and peripheral resistance in patients with chronic
heart failure: A randomized trial. JAMA 2000;283(23):
3095–101.
Jette 1991 {published data only}
Jette M, Heller R, Landry F, Blumchen G. Randomized
4 week exercise program in patients with impaired left
ventricular function. Circulation 1991;84(4):1561–7.
Keteyian 1996 {published data only}
Keteyian SJ, Levine AB, Brawner CA, Kataoka T, Rogers
FJ, Schairer JR, et al.Exercise training in patients with heart
failure. A randomized, controlled trial. Annals of Internal
Medicine 1996;124(12):1051–7.
Kiilavuori 1996 {published data only}
Kiilavuori K, Sovijarvi A, Naveri H, Ikonen T, Leinonen
H. Effect of physical training on exercise capacity and gas
exchange in patients with chronic heart failure. Chest 1996;
110(4):985–91.
Maiorana 2000 {published data only}
Maiorana A, O’Driscoll G, Cheetham C, Collis J, Goodman
C, Rankin S, et al.Combined aerobic and resistance exercise
training improves functional capacity and strength in CHF.
Journal of Applied Physiology 2000;88(5):1565–70.
Meyer 1996 {published data only}
Meyer K, Schwaibold M, Westbrook S, Beneke R, Hajric R,
Gornandt L, et al.Effects of short-term exercise training and
activity restriction on functional capacity in patients with
severe chronic congestive heart failure. American Journal of
Cardiology 1996;78(9):1017–22.
Meyer K, Schwaibold M, Westbrook S, Beneke R, Hajric R,
Lehmann M, et al.Effects of exercise training and activity
restriction on 6-minute walking test performance in patients
with chronic heart failure. American Heart Journal 1997;
133(4):447–53.
Oka 2000 {published data only}
Oka RK, De Marco T, Haskell WL, Botvinick E, Dae
MW, Bolen K, et al.Impact of a home-based walking and
resistance training program on quality of life in patients
with heart failure. American Journal of Cardiology 2000;85
(3):365–9.
Owen 2000 {published data only}
Owen A, Croucher L. Effect of an exercise programme for
elderly patients with heart failure. European Journal of Heart
Failure 2000;2(1):65–70.
Parnell 2002 {published data only}
Parnell MM, Holst DP, Kaye DM. Exercise training
increases arterial compliance in patients with congestive
heart failure. Clinical Science 2002;102(1):1–7.
Ponikowski 1997 {published data only}
Ponikowski P, Szelemej R, Kowalska-Superlak M,
Kratochwil D, Sobkowicz B, Sebzda T, et al.Exercise
rehabilitation in patients with moderate-severe chronic
heart failure. [CZY CHORZY Z NIEWYDOLNOSCIA
KRAZENIA KORZYSTAJA Z REHABILITACJI
RUCHOWEJ?]. Kardiologia Polska 1997;47(10):291–300.
Pu 2001 {published data only}
Pu CT, Johnson MT, Forman DE, Hausdorff JM,
Roubenoff R, Foldvari M, et al.Randomized trial of
progressive resistance training to counteract the myopathy
of chronic heart failure. Journal of Applied Physiology 2001;
90(6):2341–50.
Quittan 1999 {published data only}
Quittan M, Sturm B, Wiesinger GF, Pacher R, Fialka-Moser
V. Quality of life in patients with chronic heart failure: a
randomized controlled trial of changes induced by a regular
exercise program. Scandinavian Journal of Rehabilitation
Medicine 1999;31(4):223–8.
Sturm B, Quittan M, Wiesinger GF, Stanek B, Frey
B, Pacher R. Moderate-intensity exercise training with
elements of step aerobics in patients with severe chronic
heart failure. Archives of physical medicine and rehabilitation
1999;80:746–50.
Teo 1995 EXERT {published data only}
McKelvie RS, Teo KK, Roberts R, McCartney N, Humen
D, Montague T, Hendrican K, Yusuf S. Effects of exercise
training in patients with heart failure: The Exercise
Rehabilitation Trial (EXERT). American heart journal 2002;
144(23-30).
Teo K, McKelvie R, Yusuf S, McCartney N, Guyatt G,
Roberts R, et al.Randomized controlled trial of aerobic plus
resistance exercise training in patients with congestive heart
failure. The Exercise Rehab Trial (EXERT) Investigators
[abstract]. Controlled clinical trials 1995;16(3 Suppl):99S.
Tyni-Lenne 1997 {published data only}
Tyni-Lenne R, Gordon A, Jansson E, Bermann G, Sylven
C. Skeletal muscle endurance training improves peripheral
oxidative capacity, exercise tolerance, and health-related
quality of life in women with chronic congestive heart
failure secondary to either ischemic cardiomyopathy or
idiopathic dilated cardiomyopathy. American Journal of
Cardiology 1997;80(8):1025–9.
Tyni-Lenne 2001 {published data only}
Tyni-Lenne R, Dencker K, Gordon A, Jansson E,
Sylven C. Comprehensive local muscle training increases
aerobic working capacity and quality of life and decreases
9Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
neurohormonal activation in patients with chronic heart
failure. European Journal of Heart Failure 2001;3(1):47–52.
Tyni-Lenne/Gordon 96 {published data only}
Gordon A, Tyni-Lenne R, Persson H, Kaijser L, Hultman
E, Sylven C. Markedly improved skeletal muscle function
with local muscle training in patients with chronic heart
failure. Clinical Cardiology 1996;19(7):568–74.
Tyni-Lenne R, Gordon A, Sylven C. Improved quality of life
in chronic heart failure patients following local endurance
training with leg muscles. Journal of Cardiac Failure 1996;2
(2):111–7.
Wielenga 1998 {published data only}
Wielenga RP, Huisveld IA, Bol E, Dunselman PH, Erdman
RA, Baselier MR, et al.Exercise training in elderly patients
with chronic heart failure [published erratum appears in
Coron Artery Dis 1999;10(1):57]. Coronary Artery Disease
1998;9(11):765–70.
Wielenga 1999 CHANGE {published data only}
Wielenga RP, Huisveld IA, Bol E, Dunselman PH, Erdman
RA, Baselier MR, et al.Safety and effects of physical training
in chronic heart failure. Results of the Chronic Heart
Failure and Graded Exercise study (CHANGE). European
Heart Journal 1999;20(12):872–9.
Willenheimer 1998 {published data only}
Willenheimer R, Erhardt L, Cline C, Rydberg E, Israelsson
B. Exercise training in heart failure improves quality of life
and exercise capacity. European Heart Journal 1998;19(5):
774–81.
References to studies excluded from this review
Adamopoulos 1995 {published data only}
Adamopoulos S, Ponikowski P, Cerquetani E, Piepoli M,
Rosano G, Sleight P, et al.Circadian pattern of heart rate
variability in chronic heart failure patients. Effects of
physical training. European Heart Journal 1995;16(10):
1380–6.
Barnard 2000 {published data only}
Barnard KL, Adams KJ, Swank AM, Kaelin M, Kushnik
MR, Denny DM. Combined high-intensity strength and
aerobic training in patients with congestive heart failure.
Journal of strength and conditioning research 2000;14:383–8.
Belardinelli2 1995 {published data only}
Belardinelli R, Georgiou D, Scocco V, Barstow TJ, Purcaro
A. Low intensity exercise training in patients with chronic
heart failure. Journal of the American College of Cardiology
1995;26(4):975–82.
Cohen-Solal 1994 {published data only}
Cohen-Solal A, Aupetit JF, Gueret P, Kolsky H, Zannad
F. Can anaerobic threshold be used as an end-point
for therapeutic trials in heart failure? Lessons from a
multicentre randomized placebo-controlled trial. The VO2
French Study Group. European Heart Journal 1994;15(2):
236–41.
Davey 1992 {published data only}
Davey P, Meyer T, Coats A, Adamopoulos S, Casadei B,
Conway J, et al.Ventilation in chronic heart failure: Effects
of physical training. British heart journal 1992;68(5):473–7.
Gordon 1999 {published data only}
Gordon A, Tyni-Lenne R, Jansson E, Jensen-Urstad M,
Kaijser L. Beneficial effects of exercise training in heart
failure patients with low cardiac output response to exercise
- a comparison of two training models. Journal of Internal
Medicine 1999;246(2):175–82.
Johnson 1998 {published data only}
Johnson PH, Cowley AJ, Kinnear WJ. A randomized
controlled trial of inspiratory muscle training in stable
chronic heart failure. European Heart Journal 1998;19(8):
1249–53.
Kavanagh 1996 {published data only}
Kavanagh T, Myers MG, Baigrie RS, Mertens DJ, Sawyer P,
Shephard RJ. Quality of life and cardiorespiratory function
in chronic heart failure: effects of 12 months’ aerobic
training. Heart 1996;76(1):42–9.
Koch 1992 {published data only}
Koch M, Douard H, Broustet JP. The benefit of graded
physical exercise in chronic heart failure. Chest 1992;101(5
Suppl):231S–235S.
Metra 1998 {published data only}
Metra M, Nodari S, Raccagni D, Garbellini M, Boldi E,
Bontempi L, et al.Maximal and submaximal exercise testing
in heart failure. Journal of Cardiovascular Pharmacology
1998;32(Suppl 1):S36–S45.
Page 1994 {published data only}
Page E, Cohen-Solal A, Jondeau G, Douard H, Roul G,
Kantelip JP, et al.Comparison of treadmill and bicycle
exercise in patients with chronic heart failure. Chest 1994;
106(4):1002–6.
Taylor 1999 {published data only}
Taylor A. Physiological response to a short period of exercise
training in patients with chronic heart failure. Physiotherapy
Research International 1999;4(4):237–49.
Tokmakova 1999 {published data only}
Tokmakova M, Dobreva B, Kostianev S. Effects of short-
term exercise training in patients with heart failure. Folia
Medica (Plovdiv) 1999;41(1):68–71.
Tyni-Lenne 1998 {published data only}
Tyni-Lenne R, Gordon A, Europe E, Jansson E, Sylven
C. Exercise-based rehabilitation improves skeletal muscle
capacity, exercise tolerance, and quality of life in both
women and men with chronic heart failure. Journal of
Cardiac Failure 1998;4(1):9–17.
Tyni-Lenne 1999 {published data only}
Tyni-Lenne R, Gordon A, Jensen-Urstad M, Dencker K,
Jansson E, Sylven C. Aerobic training involving a minor
muscle mass shows greater efficiency than training involving
a major muscle mass in chronic heart failure patients.
Journal of Cardiac Failure 1999;5(4):300–7.
10Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
References to studies awaiting assessment
Kayanakis 1994 {published data only}
Kayanakis JG, Page E, Aros F, Borau F. [Rehabilitation of
patients with chronic cardiac insufficiency. Immediate and
midterm effects]. [French]. Presse Medicale 1994;23(3):
121–6.
References to ongoing studies
NRR ongoing trial 1 {published data only}
National Research Register, Publication ID N0201112792.
EXIST - Exercise Intervention Strategies in Heart Failure
Trial. Start date 01/07/2002, end date 31/12/2002.
NRR ongoing trial 2 {published data only}
National Research Register, Publication ID NO514100933.
A randomised trial of exercise intervention for older patients
with heart failure. Start date 01/01/2001, end date 01/01/
2004.
Additional references
AHA
American Heart Association. www.americanheart.org.
CHF Guidelines 2001
Working Group on Cardiac Rehabilitation and Exercise
Physiology and Working Group on Heart Failure of the
European Society of Cardiology. Recommendations for
exercise training in chronic heart failure patients. European
Heart Journal 2001;22:125–35.
CHF Taskforce 2001
The task force for the diagnosis and treatment of chronic
heart failure. Guidelines for the diagnosis and treatment
of chronic heart failure. European Heart Journal 2001;22:
1527–60.
Cochrane Heart Group
Cochrane Heart Group. Preferred method for handling
continuous variables. http://www.epi.bris.ac.uk/cochrane/
stats3.html. Accessed May 2004.
Conn 1982
Conn EH, Williams RS, Wallace AG. Exercise responses
before and after physical conditioning in patients with
severely depressed left ventricular function. The American
Journal of Cardiology 1982;49:296–300.
Cowie 1997
Cowie MR, Struthers AD, Wood DA, et al.Value of
natriuretic peptides in the assessment of patients with
possible new hear failure in primary care. Lancet 1997;350:
1349–53.
Dickersin 1994
Dickersin K, Scherer R, Lefebve C. Identifying relevant
studies for systematic reviews. BMJ 1994;309:1286–91.
DOH 2000
National Service Framework for Coronary Heart Disease.
http://www.doh.gov.uk/pdfs/chdnsf.pdf.
Drexler 1992
Drexler H, Riede U, Munzel T, Konig H, Funke E, Just
H. Alterations of skeletal muscle in chronic heart failure.
Circulation 1992;85:1751–9.
Dziekan 1998
Dziekan G, Myers J, Goebbels U, Muller P, Reinhart W,
Ratti R, et al.Effects of exercise training on limb blood flow
in patients with reduced ventricular function. American
Heart Journal 1998;136:22–7.
Follmann 1992
Follman D, Elliot P, Suh I, Cutler J. Variance imputation
for overviews of clinical trials with continuous response.
Journal of Clinical Epidemiology 1992;45:769–73.
Hülsmann 2002
Hülsmann M, Berger R, Sturm B, Bojic A, Woloszczuk W,
Bergler-Klein, et al.Prediction of outcome by neurohumoral
activation, the six-minute walk test and the Minnesota
living with heart failure questionnaire in an outpatient
cohort with congestive heart failure. European Heart Journal
2002;23:886–91.
Jadad 1996
Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds
JM, Gavaghan DJ, et al.Assessing the quality of reports of
clinical trials: Is blinding necessary?. Controlled Clinical
Trials 1996;17(1):1–12.
Jolliffe 2001
Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N,
Ebrahim S. Exercise based rehabilitation for coronary heart
disease (Cochrane Review). The Cochrane Library 2001,
Issue 2.
Kannel 1991
Kannel WB, Belanger AJ. Epidemiology of heart failure.
American Heart Journal 1991;121:951–7.
Kostis 1997
Kostis JB, Davis BR, Cutler J, et al.Prevention of heart
failure antihypertensive drug treatment in older persons
with isolated systemic hypertension. SHEP Cooperative
Research Group. JAMA 1997;278(3):212–6.
Lee 1979
Lee AP, Ice R, Blessey R, Sanmarco ME. Long term effects
of physical training on coronary patients with impaired
ventricular function. Circulation 1979;60(1519-26).
Lefebvre 1996
Lefebvre C, McDonald S. Development of a sensitive
search strategy for reports of randomised controlled
trials in EMBASE. Conference Abstracts for the Fourth
International Cochrane Colloquium, 20-24 Oct; Adelaide,
Australia. 1996.
Lip 2000
Lip GYH, Gibbs CR, Beevers DG. Aetiology: ABC of heart
failure. BMJ 2000;320:104–7.
Lloyd-Williams 2002
Lloyd-Williams F, Mair FS, Leitner M. Exercise training
and heart failure: A systematic review of current evidence.
British Journal of General Practice 2002;52(474):47–55.
11Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mancini 1992
Mancini DM, Walter G, Reichek N, et al.Contribution of
skeletal muscle atrophy to exercise intolerance and altered
muscle metabolism in heart failure. Circulation 1992;85:
1364–73.
McMurray 2000
McMurray JJ, Steward S. Heart failure: Epidemiology,
aetiology, and prognosis of heart failure. Heart 2000;83:
596–602.
NHS 1998
NHS Centre for Reviews and Dissemination. Cardiac
Rehabilitation. Effective Health Care Bulletin 1998;4.
O’Connor 1989
O’Connor GT, Buring JE, Yusuf S, Goldhaber SZ,
Olmstead EM, Paffenbarger RS, et al.An overview of
randomised trials of rehabilitation with exercise after
myocardial infarction. Circulation 1989;80:234–44.
Oldridge 1988
Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac
rehabilitation after myocardial infarction. Combined
experience of randomised clinical trials. JAMA 1988;260:
945–50.
Opasich 2001
Opasich C, Pinna GD, Mazza A, Febo O, Riccardi R,
Riccardi PG, et al.Six-minute walking performance in
patients with moderate-to-severe heart failure; is it a useful
indicator in clinical practice?. European Heart Journal 2001;
22(6):445–8.
Rees 2004
Rees K, Bennett PD, West RR, Davey-Smith G, Ebrahim S.
Psychological Interventions for coronary heart disease. The
Cochrane Library 2004, Issue 2.
Sullivan 1988
Sullivan MJ, Higginbotham MB, Cobb FR. Exercise
training in patients with severe left ventricular dysfunction:
hemodynamic and metabolic effects. Circulation 1988;78:
506–15.
Sullivan 1989
Sullivan MJ, Knight D, Higginbotham MB, Cobb FR.
Relation between central and peripheral hemodynamics
during exercise in patients with chronic heart failure.
Circulation 1989;80:769–81.
van den Brock 1992
van den Brock SA, van Veldhuisen DJ, de Graeff PA,
Landsman ML, Hillege H, Lie KI. Comparison between
New York Heart Association classification and peak oxygen
consumption in the assessment of functional status and
prognosis in patients with mild to moderate chronic
congestive heart failure secondary to either ischemic or
idiopathic dilated cardiomyopathy. American Journal of
Cardiology 1992;70:359–63.
Watson 2000
Watson RDS, Gibbs CR, Lip GYH. ABC of heart failure:
clinical features and complications. BMJ 2000;320:236–9.
∗ Indicates the major publication for the study
12Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Belardinelli 1992
Methods Parallel group RCT
Participants . HF diagnosis mixed, n=12 IHD, n=8 DCM. LVEF<40%. 20 patients randomised, mean age 61.5 years, 90% men
Interventions Aerobic exercise in outpatient setting for 8 weeks, 3 times a week for one hour. Workload was prgressively increased
from 40% VO2max to 65% in the last week. Follow-up assessment at end of intervention period of 8 weeks
Outcomes Exercise duration
Notes Been translated from Italian publication
Belardinelli 1995
Methods Parallel group RCT
Participants HF diagnosis mixed - n=18 IHD, n=37 DCM, NYHA class 2 or 3. 55 patients randomised, 85% men, mean age
55 years
Interventions Aerobic exercise, 1 hour 3 times a week for 8 weeks on a bike ergometer, intensity altered according to individuals
progression, patients monitored by telemetry. Follow-up assessment at 12 months
Outcomes VO2max
Peak workload
Notes
Belardinelli 1999
Methods Parallel group RCT
Participants HF diagnosis mixed - 85% ischaemic cardiomyopathy, 15% idiopathic DCM, LVEF <40%. 99 patients randomised,
89% men, mean age 59 years
Interventions Aerobic exercise - 2 phases - 8 week programme and 12 months maintainance programme. Phase 1 - warm up
stretching 15-20 minutes, 40 mins on bike ergometer for at 60% VO2max, 5 minutes cool down, 3 times a week.
Phase 2 - repeat of phase 1 but 2 times a week for remaining 12 months. Compliance from attendance at sessions -
89%. Follow-up measurement at 14 months (repeat exercise test), patients monitored for 3.3 years
Outcomes VO2max
HRQoL
Notes
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Cider 1997
Methods Parallel group RCT
Participants Mixed CHF patients, most secondary to IHD. NYHA class 2 or 3, CHF diagnosis for at least a year. 24 patients
randomised, 67% men, mean age 63 years
Interventions Strength/resistance training - peripheral dynamic training (circuit weight training regimen 60% 1 rep maximum), 60
minutes, 2 times a week for 5 months. Compliance 75%. Follow-up assessment at end of intervention at 5 months
Outcomes HRQoL
Notes
Coats 1990
Methods Cross over RCT
Participants All patients had diagnosis of HF secondary to MI, LVEF<40%. 11 patients randomised, all men, mean age 63 (7.6)
years
Interventions Aerobic exercise on bike ergometer at 70-80% maxHR. 1 minute warm up, 20 minutes cycling, 1 minute cool down,
5 days a week for 8 weeks. Exercise performed at home - patients given a HR monitor. Control group asked to avoid
exercise over and above their normal level, particularly if it caused breathlessness or fatigue. Following crossover from
the trained group, bikes were taken from them and the same activity restriction was recommended. Data has been
combined for the 2 arms, but the authors explicitly state there were no carry over effects. Compliance to exercise was
monitored by bike revolutions (mean compliance 74%). Followed up at the end of the intervention at 16 weeks
Outcomes VO2 max
Exercise duration
Notes
Coats 1992
Methods Cross over RCT
Participants All patients had diagnosis of HF secondary to MI, LVEF<40%, NYHA class 2 or 3. 19 patients randomised, all men,
mean age 61.8 years
Interventions Aerobic exercise on bike ergometer at 50 rpm for 20mins 5 times a week for 8 weeks. Bikes used at home by the
patient - given HRmonitor. Compliance from bike revolutions - mean 77.3%. Control group asked to avoid exercise
over and above their current level, particularly if it caused dyspnoea. Data combined for the 2 arms of the trial, but
the authors explicitly state there were no carry-over effects. Followed up at the end of the intervention at 16 weeks
Outcomes VO2 max
Exercise duration
Notes
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Dubach et al studies
Methods Parallel group RCT
Participants CHF secondary to CHD - all patients had had a prior MI, NYHA class 2 or 3, LVEF <40%. 25 patients randomised,
all men, mean age 55 years
Interventions Aerobic exercise - 8 week residential course in Swiss mountains. Comprehensive rehabilitation including exercise,
education and a low fat diet. Outdoor walking for 1 hour twice a day , stationary cycling 4 times a week for 45
minutes at 70-80% HR reserve. Follow-up assessment at end of intervention period of 8 weeks
Outcomes VO2max
Exercise time
Exercise capacity
Notes
Gottlieb 1999
Methods Parallel group RCT
Participants Mixed CHF - primary n=18, ischaemic n=7, NYHA 2 or 3, LVEF <40%. 33 patients randomised, 88% men, age
range 64-67 years
Interventions Aerobic exercise, 6 months supervised training 3 times a week, cycling and treadmill walking, exercise progressively
increased to perceived exertion of 12-13 on the Borg Scale. Compliance 75%. Outcome assessment at end of
intervention period of 6 months
Outcomes VO2 max
Exercise duration
Distance on 6 minute walk
Notes
Hambrecht 1995
Methods Parallel group RCT
Participants Majority of patients DCM (19/22), remainder IHD. NYHA class 2 or 3, LVEF <40%. 22 patients randomised, all
men, mean age 51 years
Interventions Aerobic exercise, 3 weeks in hospital, remainder of 6 months at home, and group sessions. Hospital - 10 minutes
6 times a day for 3 weeks on a bike ergometer under strict supervision, workload 70% VO2max. Home - asked
to exercise close to target HR (bikes and pulse rate monitoring equipment loaned to patients) twice a day for 40
minutes, plus also attend 2 group sessions per week for 1 hour each. Follow-up at end of the intervention period of
6 months
Outcomes VO2 max
Exercise duration
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Hambrecht 1995 (Continued)
Notes
Hambrecht 1998
Methods Parallel group RCT
Participants Mixed CHF - DCM n=13, CHD n=7, NYHA 2 or 3, LVEF<40%. 20 patients randomised, all men, mean age 55
years
Interventions Aerobic exercise, 3 weeks on an individual care ward and remaining 6 months at home. 3 weeks - bike ergometer 6
times daily for 10 minutes at 70% VO2max. Home - patient took bike ergometer home to exercise 5 times a week
for 40 minutes (total of twice daily), and attend 1 group session per week. Compliance to home training estimated
to be 70%. Follow-up assessment at end of intervention period of 6 months
Outcomes VO2max
Notes
Hambrecht 2000
Methods Parallel group RCT
Participants Majority of patients DCM (61/73), remainder IHD. LVEF <40%. 73 patients randomised, all men, mean age 54.5
years
Interventions Aerobic exercise, 2 weeks on an individual care ward and remaining 6 months at home. 2 weeks - bike ergometer 4-
6 times daily for 10 minutes at 70% VO2max. Home - patient took bike ergometer home to exercise 5 times a week
for 20 minutes at 70% VO2max, and attend 1 group session per week of 1 hour duration. Follow-up assessment at
end of intervention period of 6 months
Outcomes VO2 max
Exercise duration
Notes
Jette 1991
Methods Parallel group RCT
Participants CHF secondary to MI, NYHA 2 or 3 and LVEF<50%. 39 patients randomised, all men, mean age 50.8 years
Interventions Aerobic exercise 5 days a week for 4 weeks - jogging 5 mins 3 times a day, cycling 15 mins (both at 70-80% max
HR), calisthenics (30 mins) and relaxation training (20 mins). Follow-up assessment at end of intervention period
at 4 weeks
Outcomes VO2max
Peak workload
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Jette 1991 (Continued)
Notes
Keteyian 1996
Methods Parallel group RCT
Participants Mixed CHF - IHD (n=9) and DCM (n=20) CHF patients, NYHA 2 or 3, LVEF 35% or less. All men, mean age 54
years
Interventions Aerobic exercise, 45 minutes (5 mins warm up, 35 mins 3 types aerobic activity, 5 mins cool down) 3 times a week
for 24 weeks. Follow-up measurements at 24 weeks
Outcomes VO2max
Exercise duration
Notes
Kiilavuori 1996
Methods Parallel group RCT
Participants Mixed CHF - CHD (n=9) and DCM (n=18), NYHA 2 or 3, LVEF<40%. 27 patients randomised, 96% men, mean
age 52 years
Interventions Aerobic exercise - 3 months supervised, 3 months home based. Supervised - bike ergometer 30 mins 3 times a week
at 50-60% VO2max for 2-3 weeks, then increased workload depending on individual HR thereafter. Home based
- walking, rowing, cycling or swimming depending on individual instruction. Control group advised not to change
their previous physical activity during the 6 months. Follow-up assessment at 6 months
Outcomes VO2max
Exercise duration
Notes
Maiorana 2000
Methods Cross over RCT
Participants Mixed CHF, n=7 CHD, n=6 DCM, NYHA 1-3, LVEF mean 26%. 13 patients randomised, all men, mean age 60
years
Interventions Aerobic and resistance training. 8 weeks training, 1 hour 3 times a week. Whole body exercise concentrating on
the large muscle groups. Combination of circuit training, cycle ergometry, treadmill and resistance weight training.
Intensity and duration of exercise gradually increased over the 8 week period. Follow-up assessment at 16 weeks (cross
over trial)
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Maiorana 2000 (Continued)
Outcomes VO2max
Exercise duration
Notes
Meyer 1996
Methods Cross over RCT
Participants Severe CHF, patients are hospitalised. Mix of CHF due to DCM (n=9) and IHD (n=9). 18 patients randomised, all
men, mean age 52 years
Interventions Aerobic and resistance training. 3 weeks in hospital training on bike ergometer and treadmill at 50% max work
rate,10-15 minutes 3-5 times per week for each exercise respectively. Also muscle strength exercises, coordination
and inspiratory muscle training 3 times a week for 20 minutes. Follow up after 6 week intervention period. Data
presented combined for the 2 arms, but authors explicitly state that no evidence of carry-over effects was found
Outcomes VO2 max
Peak workload (Watts)
Notes
Oka 2000
Methods Parallel group RCT
Participants Mixed CHF, LVEF <40%. 40 patients randomised, 77.5% men, age range 30-76 years
Interventions Aerobic and resistance training at home for 3 months. Walking at home 3 times a week increasing the intensity and
duration over the initial 2-3 weeks to 70% peak HR for 40-60 minutes. Total body unilateral resistance exercises
2 times a week up to 75% 1 rep max. Weekly phonecalls to answer questions and monitor adherence. Follow-up
assessment at end of intervention period of 3 months
Outcomes VO2max
Exercise duration
HRQoL
Notes
Owen 2000
Methods Cross over RCT
Participants Mixed aetiology of CHF, 67% CHD, 33% AF, LVEF<40%. Focus on the elderly >75 years, mean age 81 years, 75%
men. 22 patients randomised
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Owen 2000 (Continued)
Interventions Resistance training - 6 station circuit with stations alternating between stamina and strengthening exercises. Patients
worked in a range comfortable to them and warned not to exceed 70% max HR (showed how to monitor this).
Average session 1 hour, once a week for 12 weeks. Follow-up assessment at end of intervention period at 24 weeks
(cross over trial)
Outcomes Distance on 6 min walk
Notes
Parnell 2002
Methods Parallel group RCT
Participants Mixed aetiology of CHF, NYHA 2 or 3. 21 patients randomised, 91% men, age range 53-57 years
Interventions Aerobic exercise - 8 weeks of walking, cycling and light weights at 50-60%maximumHR, increasing exercise duration
progressively from 30 mins-60 mins per day for 5-7 days per week. Follow-up assessment at end of intervention
period of 8 weeks
Outcomes Distance on 6 min walk
HRQoL
Notes
Ponikowski 1997
Methods Parallel group RCT
Participants Mixed aetiology of CHF, most (88%) CHD, 12% DCM, LVEF <45%. 32 patients randomised, 81% men, mean
age 57 years
Interventions Aerobic exercise training - first 1-2 weeks in hospital, following modified Royal Canadian Airforce Training pro-
gramme, and graded walking, under the supervision of a physiotherapist (max HR 75-80%). 35-45 mins exercise
per day. For remaining 16 weeks, similar walking programme to be done individually at home for 6 days each week.
Comparison group - usual care. Follow-up assessment at end of 16 weeks
Outcomes VO2max
Exercise duration
Peak workload (Watts)
Clinical outcomes.
HRQoL
Notes Been translated from Polish publication
19Exercise based rehabilitation for heart failure (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pu 2001
Methods Parallel group RCT
Participants Mixed group of mild-moderate CHF, ischaemic and idiopathic, NYHA class 1-3. All women over the age of 65 years
(mean 77 years), 16 patients randomised
Interventions Resistance training - high intensity progressive training 3 times a week for 10 weeks, 1 hour sessions. Dynamic
contraction of large upper and lower body groups, at 80% weight that could be lifted in good form (1 repetition
max). Control group received “placebo” controlled stretching. Attendance at classes averaged 98% in both groups.
Follow-up assessment at end of intervention period of 10 weeks
Outcomes VO2max
Distance on 6 min walk
Notes
Quittan 1999
Methods Parallel group RCT
Participants All DCM patients, NYHA 2 or 3, LVEF <30%. 25 patients randomised, 81.5% men, mean age 55.3 years
Interventions Aerobic exercise programme - 3 months bike ergometer training and step exercises 1 hour (short warm up and cool
down and 2 times 25minutes training) 2-3 times per week, at 50%maximal functional capacity. Follow up assessment
at end of intervention period of 3 months
Outcomes VO2max
Exercise duration
HRQoL
Notes
Teo 1995 EXERT
Methods Parallel group RCT
Participants Mixed CHF, for majority of patients CHD (76%), NYHA 1-3, LVEF >40%. 181 patients randomised, 81% men,
mean age 65.5 years
Interventions Aerobic and resistance training in supervised rehabilitation programme for 3 months and continued home based
training for a further 9 months. Aerobic training HR set at 60-70% maximum HR. Cycle, treadmill and arm
ergometry exercise for 30 mins per session twice a week and walking at home once a week. Supervised resistance
training twice a week at 40-60% 1 repetition maximum - arm curls, knee extensions and leg press. After 3 months
patients provided with a bike and set of free weight and instructed to train 3 times a week for remaining 9 months.
Follow-up assessment at 12 months
Outcomes Distance on 6 min walk
HRQoL
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Teo 1995 EXERT (Continued)
Notes
Tyni-Lenne 1997
Methods Cross over RCT
Participants Aetiology of CHF both CHD (n=8) and DCM (n=8). NYHA class 2 or 3, LVEF<40%. 16 patients randomised -
all women, mean age 62 years
Interventions Endurance training of leg muscles 3 times a week for 8 weeks on a modified knee extensor ergometer. 15 minutes
at 60 reps per minutes intensity progressively increasing from 65-75% peak work rate. Follow-up at the end of 16
weeks (crossover study)
Outcomes VO2 max
Distance on 6 minute walk
Notes Contacted authors re: QoL data
Tyni-Lenne 2001
Methods Parallel group RCT
Participants Aetiology of CHF both CHD and DCM. LVEF<40% and NYHA class 2 or 3. 24 patients randomised, 54% men,
mean age 62.5 years. Randomisation to intervention 2:1
Interventions Strength/resistance exercise using resistance rubber bands. 8 weeks supervised group exercise 3 times a week for 1
hour. 6 minutes warm up, 45 minutes training - continuous repetitive contractions against a resistance - one muscle
group at a time with 25 reps, 9 minutes cool down. Compliance measured as attendance - 95%. Follow-up assessment
at the end of the 8 week intervention period
Outcomes VO2 max
Distance on 6 minute walk HRQoL
Notes
Tyni-Lenne/Gordon 96
Methods Parallel group RCT
Participants Aetiology of CHF both CHD and DCM. NYHA class 2 or 3. 21 patients randomised, all men, mean age 60 years
Interventions Endurance training with continuous knee extensor exercises at 60 reps per minute performed on a modified bike
ergometer. Two intervention groups - 1 legged exercise and 2 legged exercise where the same relative quantity of
muscle work per session was performed, but the quantity of muscle mass activated was different. 8 weeks of training
3 times a week for 25-40 minutes. Compliance estimated to be between 90-100%. Follow-up assessment at the end
of the intervention period at 8 weeks
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Tyni-Lenne/Gordon 96 (Continued)
Outcomes Distance on 6 minute walk
HRQoL
VO2max (Gordon 96)
Notes Assuming same study as Gordon 1996. VO2max measured in that study
Wielenga 1998
Methods Parallel group RCT
Participants Aetiology of CHF both CHD and DCM. LVEF <40% and NYHA class 2 or 3. 67 patients randomised, all men,
mean age 64 years. Patients stratified and outcomes expressed in terms of those greater and less than 65 years of age
Interventions Aerobic exercise training - 12 weeks training 3 times a week - 45 minute sessions of walking, cycling and ball games
10 mins each with 5 mins rest. Target HR maintained for at least 20 minutes. Follow-up assessment at end of
intervention period of 12 weeks
Outcomes VO2max
Exercise duration
Notes
Wielenga 1999 CHANGE
Methods Parallel group RCT
Participants Aetiology of CHF both CHD and DCM. LVEF <40% and NYHA class 2 or 3. 80 patients randomised, all men,
mean age 56.6 years
Interventions Aerobic exercise, 12 weeks training 3 times a week, comprising 3 exercises for 10 mins each separated by 5 mins rest
(cycling, walking and ball games), at 60% max HR. Walking progressed to slow running during the course of the
training period. 85.4% compliance. Follow-up assessment at end of the intervention period of 12 weeks
Outcomes VO2max
Exercise duration
Notes
Willenheimer 1998
Methods Parallel group RCT
Participants Aetiology of CHF both CHD (75%) and DCM. Boston HF criteria and LVEF <45%. 54 patients randomised, 71.
5% men, mean age 64 years
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Willenheimer 1998 (Continued)
Interventions Aerobic exercise - 16 weeks interval training on a bike ergometer - 90 seconds exercise at 80% VO2 max, 30 seconds
rest. Exercise time gradually increased from 15 minutes total 2 times a week to 45 minutes 3 times a week from week
7. Mean compliance 74.5%. Follow-up assessment at end of intervention period of 16 weeks
Outcomes VO2max
Peak workload (Watts)
Notes
AF: atrial fibrillation
CHF: chronic heart failure
CHD: coronary heart disease
DCM : dilated cardiomyopathy
HR: heart rate
HRQoL: health related quality of life
LVEF: left ventricular ejection fraction
Mins: minutes
NYHA: New York Heart Association classification
QoL: quality of life
RCT : randomised controlled trial
VO2max: peak oxygen uptake
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adamopoulos 1995 No relevant outcomes
Barnard 2000 No relevant outcomes
Belardinelli2 1995 Not an RCT
Cohen-Solal 1994 Not an RCT
Davey 1992 As stated in Coats 1992, there is overlap in some of the patients taking part in each trial. Efforts have been
made to obtain data for those that participated only in the Davey trial but these studies were conducted over
10 years ago. To be conservative we have excluded this study from the analyses
Gordon 1999 Exercise versus exercise comparison - not usual care
Johnson 1998 Inspiratory muscle training, not whole body training
Kavanagh 1996 Not an RCT
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(Continued)
Koch 1992 Only relevant outcome was QoL with little detail given in the paper. Written to the authors for the data
available but no response
Metra 1998 Not an RCT
Page 1994 Exercise versus exercise comparison - not usual care
Taylor 1999 No baseline data were presented in the publication for the outcomes of interest. Written to authors to try to
obtain these, but no response
Tokmakova 1999 No data were presented for the control group in the publication. Written to authors to try to obtain these, but
no response
Tyni-Lenne 1998 Not an RCT
Tyni-Lenne 1999 Patients were previously trained
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D A T A A N D A N A L Y S E S
Comparison 1. All exercise interventions versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cardiac mortality 1 99 Odds Ratio (M-H, Fixed, 95% CI) 0.32 [0.13, 0.80]
2 Non-fatal Myocardial Infarction 1 99 Odds Ratio (M-H, Fixed, 95% CI) 0.48 [0.04, 5.47]
3 Hospital readmission for Heart
Failure
1 99 Odds Ratio (M-H, Fixed, 95% CI) 0.28 [0.09, 0.85]
4 Deaths not associated with
training but reported reasons
for loss to follow-up
9 483 Odds Ratio (M-H, Fixed, 95% CI) 1.12 [0.58, 2.15]
5 VO2 max (ml/kg/min) 24 848 Mean Difference (IV, Random, 95% CI) -2.16 [-2.82, -1.49]
6 Exercise duration (mins) 15 510 Mean Difference (IV, Fixed, 95% CI) -2.38 [-2.85, -1.92]
7 Maximum work capacity (Watts) 6 219 Mean Difference (IV, Fixed, 95% CI) -15.13 [-17.67, -12.
59]
8 Distance on 6 minute walk
(meters)
8 282 Mean Difference (IV, Random, 95% CI) -40.87 [-64.65, -17.
10]
Comparison 2. Subgroup analyses
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 VO2 max (ml/kg/min) 24 4191 Mean Difference (IV, Random, 95% CI) -2.19 [-2.48, -1.90]
1.1 “Dose” of intervention
=/> 30 units
11 432 Mean Difference (IV, Random, 95% CI) -2.78 [-3.88, -1.69]
1.2 “Dose” of intervention <
30 units
13 416 Mean Difference (IV, Random, 95% CI) -1.64 [-2.15, -1.12]
1.3 Jadad score = 3 and above 7 341 Mean Difference (IV, Random, 95% CI) -2.01 [-2.90, -1.12]
1.4 Jadad score = 2 and below 15 458 Mean Difference (IV, Random, 95% CI) -2.28 [-3.47, -1.10]
1.5 Duration of intervention
>12 weeks
10 420 Mean Difference (IV, Random, 95% CI) -2.62 [-3.76, -1.48]
1.6 Duration of intervention
=/<12 weeks
14 428 Mean Difference (IV, Random, 95% CI) -1.79 [-2.33, -1.24]
1.7 Mean age > 55 years 15 540 Mean Difference (IV, Random, 95% CI) -1.77 [-2.50, -1.03]
1.8 Mean age =/< 55 years 9 308 Mean Difference (IV, Random, 95% CI) -2.95 [-4.25, -1.64]
1.9 Duration of follow up >
16 weeks
9 397 Mean Difference (IV, Random, 95% CI) -2.74 [-3.83, -1.65]
1.10 Duration of follow up
=/< 16 weeks
15 451 Mean Difference (IV, Random, 95% CI) -1.55 [-2.17, -0.94]
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Analysis 1.1. Comparison 1 All exercise interventions versus usual care, Outcome 1 Cardiac mortality.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 1 All cause mortality up to12 month follow up
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 5/85 4/94 8.8 % 1.38 [ 0.38, 4.98 ]
Dracup 2007 9/87 8/86 18.6 % 1.11 [ 0.45, 2.75 ]
Giannuzzi 2003 0/45 1/45 3.5 % 0.33 [ 0.01, 7.97 ]
Gielen 2003 0/10 0/10 Not estimable
Gottlieb 1999 1/17 1/16 2.4 % 0.94 [ 0.06, 13.82 ]
Hambrecht 1995 1/12 0/10 1.3 % 2.54 [ 0.11, 56.25 ]
Hambrecht 1998 1/10 1/10 2.3 % 1.00 [ 0.07, 13.87 ]
Hambrecht 2000 3/36 2/37 4.6 % 1.54 [ 0.27, 8.69 ]
Keteyian 1996 0/21 1/19 3.6 % 0.30 [ 0.01, 7.02 ]
Klecha 2007 0/25 0/25 Not estimable
McKelvie 2002 19/90 20/91 46.0 % 0.96 [ 0.55, 1.68 ]
Pozehl 2008 0/15 1/6 4.8 % 0.15 [ 0.01, 3.16 ]
Willenheimer 2000 3/27 2/33 4.2 % 1.83 [ 0.33, 10.19 ]
Total (95% CI) 480 482 100.0 % 1.02 [ 0.70, 1.51 ]
Total events: 42 (Treatment), 41 (Control)
Heterogeneity: Chi2 = 3.89, df = 10 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
0.002 0.1 1 10 500
Favours exercise Favours control
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Analysis 1.2. Comparison 1 All exercise interventions versus usual care, Outcome 2 Non-fatal Myocardial
Infarction.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 2 All cause mortality more than 12 months follow up
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 31/85 38/94 10.8 % 0.85 [ 0.46, 1.55 ]
Belardinelli 1999 9/50 20/49 7.8 % 0.32 [ 0.13, 0.80 ]
HF ACTION 2009 189/1159 198/1171 77.8 % 0.96 [ 0.77, 1.19 ]
Mueller 2007 9/25 12/25 3.6 % 0.61 [ 0.20, 1.89 ]
Total (95% CI) 1319 1339 100.0 % 0.88 [ 0.73, 1.07 ]
Total events: 238 (Experimental), 268 (Control)
Heterogeneity: Chi2 = 5.69, df = 3 (P = 0.13); I2 =47%
Test for overall effect: Z = 1.24 (P = 0.21)
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 1.3. Comparison 1 All exercise interventions versus usual care, Outcome 3 Hospital readmission
for Heart Failure.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 3 Hospital admission up to 12 month follow up
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 9/85 19/94 28.9 % 0.52 [ 0.25, 1.09 ]
Dracup 2007 35/87 37/86 59.5 % 0.94 [ 0.66, 1.33 ]
Giannuzzi 2003 2/45 1/45 1.6 % 2.00 [ 0.19, 21.28 ]
Gielen 2003 1/10 0/10 0.8 % 3.00 [ 0.14, 65.90 ]
Hambrecht 1995 0/12 1/10 2.6 % 0.28 [ 0.01, 6.25 ]
Keteyian 1996 0/21 1/19 2.5 % 0.30 [ 0.01, 7.02 ]
Klecha 2007 0/25 0/25 Not estimable
Passino 2006 0/44 2/41 4.1 % 0.19 [ 0.01, 3.78 ]
Total (95% CI) 329 330 100.0 % 0.79 [ 0.58, 1.07 ]
Total events: 47 (Experimental), 61 (Control)
Heterogeneity: Chi2 = 5.07, df = 6 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
0.005 0.1 1 10 200
Favours exercise Favours control
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Analysis 1.4. Comparison 1 All exercise interventions versus usual care, Outcome 4 Deaths not associated
with training but reported reasons for loss to follow-up.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 4 Hospital admission more than 12 months follow up
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 28/85 33/94 3.9 % 0.94 [ 0.62, 1.41 ]
Belardinelli 1999 5/50 14/49 1.8 % 0.35 [ 0.14, 0.90 ]
HF ACTION 2009 729/1159 760/1171 94.0 % 0.97 [ 0.91, 1.03 ]
Mueller 2007 2/25 3/25 0.4 % 0.67 [ 0.12, 3.65 ]
Total (95% CI) 1319 1339 100.0 % 0.96 [ 0.90, 1.02 ]
Total events: 764 (Treatment), 810 (Control)
Heterogeneity: Chi2 = 4.74, df = 3 (P = 0.19); I2 =37%
Test for overall effect: Z = 1.45 (P = 0.15)
0.01 0.1 1 10 100
Favours exercise Favours control
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Analysis 1.5. Comparison 1 All exercise interventions versus usual care, Outcome 5 VO2 max (ml/kg/min).
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 5 Hospital admission heart failure only
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Belardinelli 1999 5/50 14/49 22.5 % 0.35 [ 0.14, 0.90 ]
Dracup 2007 35/87 37/86 59.3 % 0.94 [ 0.66, 1.33 ]
Giannuzzi 2003 2/45 1/45 1.6 % 2.00 [ 0.19, 21.28 ]
Hambrecht 1995 0/12 1/10 2.6 % 0.28 [ 0.01, 6.25 ]
Mueller 2007 2/25 3/25 4.8 % 0.67 [ 0.12, 3.65 ]
Passino 2006 0/44 2/41 4.1 % 0.19 [ 0.01, 3.78 ]
Willenheimer 2000 0/23 3/27 5.1 % 0.17 [ 0.01, 3.07 ]
Total (95% CI) 286 283 100.0 % 0.72 [ 0.52, 0.99 ]
Total events: 44 (Treatment), 61 (Control)
Heterogeneity: Chi2 = 7.17, df = 6 (P = 0.31); I2 =16%
Test for overall effect: Z = 2.03 (P = 0.042)
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Analysis 1.6. Comparison 1 All exercise interventions versus usual care, Outcome 6 Exercise duration
(mins).
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 6 Health related quality of life - MLWHF
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 95 22.9 (14.7) 94 36.9 (21.3) 20.0 % -14.00 [ -19.22, -8.78 ]
Belardinelli 1999 48 39 (20) 46 52 (20) 16.1 % -13.00 [ -21.09, -4.91 ]
Dracup 2007 87 35.7 (23.7) 86 43.2 (26.5) 16.9 % -7.50 [ -14.99, -0.01 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 16.8 % -11.10 [ -18.65, -3.55 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 19.3 % -0.10 [ -5.86, 5.66 ]
Passino 2006 44 32 (26.5) 41 53 (32) 10.9 % -21.00 [ -33.54, -8.46 ]
Total (95% CI) 347 353 100.0 % -10.33 [ -15.89, -4.77 ]
Heterogeneity: Tau2 = 33.04; Chi2 = 17.49, df = 5 (P = 0.004); I2 =71%
Test for overall effect: Z = 3.64 (P = 0.00027)
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Analysis 1.7. Comparison 1 All exercise interventions versus usual care, Outcome 7 Maximum work
capacity (Watts).
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 7 Health related quality of life - all scales
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 95 22.9 (14.7) 94 36.9 (21.3) 13.1 % -0.76 [ -1.06, -0.47 ]
Belardinelli 1999 48 39 (20) 46 52 (20) 11.2 % -0.64 [ -1.06, -0.23 ]
Dracup 2007 87 35.7 (23.7) 86 43.2 (26.5) 13.0 % -0.30 [ -0.60, 0.00 ]
HF ACTION 2009 1159 -5.21 (13.72) 1171 -3.28 (13.97) 15.6 % -0.14 [ -0.22, -0.06 ]
Klocek 2005 (High) 14 -109 (23.5) 7 -71.7 (23.5) 4.4 % -1.52 [ -2.57, -0.48 ]
Klocek 2005 (Low) 14 -99 (23.5) 7 -71.7 (23.5) 4.8 % -1.12 [ -2.10, -0.13 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 7.2 % -0.99 [ -1.69, -0.28 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 12.2 % -0.01 [ -0.36, 0.35 ]
Passino 2006 44 32 (26.5) 41 53 (32) 10.8 % -0.71 [ -1.15, -0.27 ]
Willenheimer 2000 20 -0.7 (0.8) 17 0 (1) 7.6 % -0.76 [ -1.44, -0.09 ]
Total (95% CI) 1554 1555 100.0 % -0.56 [ -0.82, -0.30 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 43.25, df = 9 (P<0.00001); I2 =79%
Test for overall effect: Z = 4.27 (P = 0.000020)
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Analysis 1.8. Comparison 1 All exercise interventions versus usual care, Outcome 8 Distance on 6 minute
walk (meters).
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 8 Distance on 6 minute walk (meters)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Gottlieb 1999 11 -44.8 (59.2) 14 -18.6 (40.9) 13.1 % -26.20 [ -67.22, 14.82 ]
Owen 2000 15 -21.7 (42) 9 18.4 (31) 16.1 % -40.10 [ -69.46, -10.74 ]
Parnell 2002 11 -73 (30.5) 10 -2 (25.3) 17.6 % -71.00 [ -94.89, -47.11 ]
Pu 2001 9 -49 (139) 7 3 (97) 3.5 % -52.00 [ -167.80, 63.80 ]
Teo 1995 EXERT 64 -17 (64) 78 -20 (78) 17.8 % 3.00 [ -20.36, 26.36 ]
Tyni-Lenne 1997 8 -37 (78.8) 8 2 (64) 7.5 % -39.00 [ -109.35, 31.35 ]
Tyni-Lenne 2001 16 -55 (61.6) 8 0 (30) 14.2 % -55.00 [ -91.65, -18.35 ]
Tyni-Lenne/Gordon 96 7 -56 (38.4) 7 7 (61.4) 10.2 % -63.00 [ -116.65, -9.35 ]
Total (95% CI) 141 141 100.0 % -40.87 [ -64.65, -17.10 ]
Heterogeneity: Tau2 = 687.04; Chi2 = 21.22, df = 7 (P = 0.003); I2 =67%
Test for overall effect: Z = 3.37 (P = 0.00075)
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Analysis 2.1. Comparison 2 Subgroup analyses, Outcome 1 VO2 max (ml/kg/min).
Review: Exercise based rehabilitation for heart failure
Comparison: 2 Subgroup analyses
Outcome: 1 VO2 max (ml/kg/min)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 ”Dose” of intervention =/> 30 units
Belardinelli 1999 48 -4.2 (1.55) 46 -0.8 (2) 1.6 % -3.40 [ -4.13, -2.67 ]
Dubach et al studies 12 -5.7 (4) 13 -1 (4.1) 0.6 % -4.70 [ -7.88, -1.52 ]
Gottlieb 1999 11 -2.4 (2.8) 14 -0.1 (2.6) 0.9 % -2.30 [ -4.44, -0.16 ]
Hambrecht 1995 9 -5.8 (3.6) 9 0 (2.7) 0.6 % -5.80 [ -8.74, -2.86 ]
Hambrecht 1998 9 -4.7 (1.17) 9 0.7 (1.48) 1.3 % -5.40 [ -6.63, -4.17 ]
Hambrecht 2000 31 -1.26 (4.3) 33 -0.3 (4.3) 0.9 % -0.96 [ -3.07, 1.15 ]
Keteyian 1996 15 -2.5 (2.3) 14 -0.5 (1.87) 1.2 % -2.00 [ -3.52, -0.48 ]
Kiilavuori 1996 12 -2.4 (7.3) 15 0.1 (5.4) 0.3 % -2.50 [ -7.45, 2.45 ]
Oka 2000 18 -0.52 (4.27) 18 0 (3.8) 0.7 % -0.52 [ -3.16, 2.12 ]
Ponikowski 1997 16 -2 (3.8) 13 0.5 (4) 0.7 % -2.50 [ -5.36, 0.36 ]
Wielenga 1998 35 -1.44 (3.05) 32 -0.63 (3) 1.2 % -0.81 [ -2.26, 0.64 ]
Subtotal (95% CI) 216 216 10.0 % -2.78 [ -3.88, -1.69 ]
Heterogeneity: Tau2 = 2.17; Chi2 = 38.21, df = 10 (P = 0.00003); I2 =74%
Test for overall effect: Z = 4.97 (P < 0.00001)
2 ”Dose” of intervention < 30 units
Belardinelli 1995 36 -1.15 (1.36) 19 0.8 (1.54) 1.5 % -1.95 [ -2.77, -1.13 ]
Coats 1990 10 -3.2 (3.8) 10 -0.8 (3.5) 0.6 % -2.40 [ -5.60, 0.80 ]
Coats 1992 17 -2.4 (4.5) 17 0 (4.3) 0.6 % -2.40 [ -5.36, 0.56 ]
Jette 1991 18 -1.52 (3.6) 18 0.1 (3.43) 0.8 % -1.62 [ -3.92, 0.68 ]
Maiorana 2000 13 -2.6 (4.6) 13 -0.1 (4.14) 0.5 % -2.50 [ -5.86, 0.86 ]
Meyer 1996 18 -2.4 (7) 18 -0.4 (0.7) 0.6 % -2.00 [ -5.25, 1.25 ]
Pu 2001 9 0.42 (4.1) 7 -0.35 (2.74) 0.5 % 0.77 [ -2.59, 4.13 ]
Quittan 1999 11 -2.6 (3) 12 -0.7 (2.95) 0.8 % -1.90 [ -4.33, 0.53 ]
Tyni-Lenne 1997 8 -2 (2.35) 8 0.1 (1.8) 0.9 % -2.10 [ -4.15, -0.05 ]
Tyni-Lenne 2001 16 -1.1 (4.24) 8 1.6 (3.45) 0.6 % -2.70 [ -5.87, 0.47 ]
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(. . . Continued)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Tyni-Lenne/Gordon 96 7 -0.5 (2.83) 7 0.3 (4.6) 0.4 % -0.80 [ -4.80, 3.20 ]
Wielenga 1999 CHANGE 35 -1.4 (2.95) 32 -0.6 (3.4) 1.2 % -0.80 [ -2.33, 0.73 ]
Willenheimer 1998 22 -0.9 (2.6) 27 0.1 (1.9) 1.3 % -1.00 [ -2.30, 0.30 ]
Subtotal (95% CI) 220 196 10.4 % -1.64 [ -2.15, -1.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.21, df = 12 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 6.19 (P < 0.00001)
3 Jadad score = 3 and above
Belardinelli 1995 36 -1.15 (1.36) 19 0.8 (1.54) 1.5 % -1.95 [ -2.77, -1.13 ]
Belardinelli 1999 48 -4.2 (1.55) 46 -0.8 (2) 1.6 % -3.40 [ -4.13, -2.67 ]
Coats 1990 10 -3.2 (3.8) 10 -0.8 (3.5) 0.6 % -2.40 [ -5.60, 0.80 ]
Hambrecht 2000 31 -1.26 (4.3) 33 -0.3 (4.3) 0.9 % -0.96 [ -3.07, 1.15 ]
Jette 1991 18 -1.52 (3.6) 18 0.1 (3.43) 0.8 % -1.62 [ -3.92, 0.68 ]
Quittan 1999 11 -2.6 (3) 12 -0.7 (2.95) 0.8 % -1.90 [ -4.33, 0.53 ]
Willenheimer 1998 22 -0.9 (2.6) 27 0.1 (1.9) 1.3 % -1.00 [ -2.30, 0.30 ]
Subtotal (95% CI) 176 165 7.5 % -2.01 [ -2.90, -1.12 ]
Heterogeneity: Tau2 = 0.73; Chi2 = 15.27, df = 6 (P = 0.02); I2 =61%
Test for overall effect: Z = 4.42 (P < 0.00001)
4 Jadad score = 2 and below
Coats 1992 17 -2.4 (4.5) 17 0 (4.3) 0.6 % -2.40 [ -5.36, 0.56 ]
Dubach et al studies 12 -5.7 (4) 13 -1 (4.1) 0.6 % -4.70 [ -7.88, -1.52 ]
Hambrecht 1995 9 -5.8 (3.6) 9 0 (2.7) 0.6 % -5.80 [ -8.74, -2.86 ]
Hambrecht 1998 9 -4.7 (1.17) 9 0.7 (1.48) 1.3 % -5.40 [ -6.63, -4.17 ]
Kiilavuori 1996 12 -2.4 (7.3) 15 0.1 (5.4) 0.3 % -2.50 [ -7.45, 2.45 ]
Maiorana 2000 13 -2.6 (4.6) 13 -0.1 (4.14) 0.5 % -2.50 [ -5.86, 0.86 ]
Meyer 1996 18 -2.4 (7) 18 -0.4 (0.7) 0.6 % -2.00 [ -5.25, 1.25 ]
Oka 2000 18 -0.52 (4.27) 18 0 (3.8) 0.7 % -0.52 [ -3.16, 2.12 ]
Ponikowski 1997 16 -2 (3.8) 13 0.5 (4) 0.7 % -2.50 [ -5.36, 0.36 ]
Pu 2001 9 0.42 (3) 12 -0.7 (2.95) 0.7 % 1.12 [ -1.45, 3.69 ]
Tyni-Lenne 1997 8 -2 (2.35) 8 0.1 (1.8) 0.9 % -2.10 [ -4.15, -0.05 ]
Tyni-Lenne 2001 16 -1.1 (4.24) 8 1.6 (3.45) 0.6 % -2.70 [ -5.87, 0.47 ]
Tyni-Lenne/Gordon 96 7 -0.5 (2.83) 7 0.3 (4.6) 0.4 % -0.80 [ -4.80, 3.20 ]
Wielenga 1998 35 -1.44 (3.05) 32 -0.63 (3) 1.2 % -0.81 [ -2.26, 0.64 ]
Wielenga 1999 CHANGE 35 -1.4 (2.95) 32 -0.6 (3.4) 1.2 % -0.80 [ -2.33, 0.73 ]
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 234 224 11.0 % -2.28 [ -3.47, -1.10 ]
Heterogeneity: Tau2 = 3.49; Chi2 = 48.60, df = 14 (P = 0.00001); I2 =71%
Test for overall effect: Z = 3.79 (P = 0.00015)
5 Duration of intervention >12 weeks
Belardinelli 1999 48 -4.2 (1.55) 46 -0.8 (2) 1.6 % -3.40 [ -4.13, -2.67 ]
Gottlieb 1999 11 -2.4 (2.8) 14 -0.1 (2.6) 0.9 % -2.30 [ -4.44, -0.16 ]
Hambrecht 1995 9 -5.8 (3.6) 9 0 (2.7) 0.6 % -5.80 [ -8.74, -2.86 ]
Hambrecht 1998 9 -4.7 (1.17) 9 0.7 (1.48) 1.3 % -5.40 [ -6.63, -4.17 ]
Hambrecht 2000 31 -1.26 (4.3) 33 -0.3 (4.3) 0.9 % -0.96 [ -3.07, 1.15 ]
Keteyian 1996 15 -2.5 (2.3) 14 -0.5 (1.87) 1.2 % -2.00 [ -3.52, -0.48 ]
Kiilavuori 1996 12 -2.4 (7.3) 15 0.1 (5.4) 0.3 % -2.50 [ -7.45, 2.45 ]
Ponikowski 1997 16 -2 (3.8) 13 0.5 (4) 0.7 % -2.50 [ -5.36, 0.36 ]
Wielenga 1998 35 -1.44 (3.05) 32 -0.63 (3) 1.2 % -0.81 [ -2.26, 0.64 ]
Willenheimer 1998 22 -0.9 (2.6) 27 0.1 (1.9) 1.3 % -1.00 [ -2.30, 0.30 ]
Subtotal (95% CI) 208 212 10.0 % -2.62 [ -3.76, -1.48 ]
Heterogeneity: Tau2 = 2.33; Chi2 = 42.50, df = 9 (P<0.00001); I2 =79%
Test for overall effect: Z = 4.50 (P < 0.00001)
6 Duration of intervention =/<12 weeks
Belardinelli 1995 36 -1.15 (1.36) 19 0.8 (1.54) 1.5 % -1.95 [ -2.77, -1.13 ]
Coats 1990 10 -3.2 (3.8) 10 -0.8 (3.5) 0.6 % -2.40 [ -5.60, 0.80 ]
Coats 1992 17 -2.4 (4.5) 17 0 (4.3) 0.6 % -2.40 [ -5.36, 0.56 ]
Dubach et al studies 12 -5.7 (4) 13 -1 (4.1) 0.6 % -4.70 [ -7.88, -1.52 ]
Jette 1991 18 -1.52 (3.6) 18 0.1 (3.43) 0.8 % -1.62 [ -3.92, 0.68 ]
Maiorana 2000 13 -2.6 (4.6) 13 -0.1 (4.14) 0.5 % -2.50 [ -5.86, 0.86 ]
Meyer 1996 18 -2.4 (7) 18 -0.4 (0.7) 0.6 % -2.00 [ -5.25, 1.25 ]
Oka 2000 18 -0.52 (4.27) 18 0 (3.8) 0.7 % -0.52 [ -3.16, 2.12 ]
Pu 2001 9 0.42 (4.1) 7 -0.35 (2.74) 0.5 % 0.77 [ -2.59, 4.13 ]
Quittan 1999 11 -2.6 (3) 12 -0.7 (2.95) 0.8 % -1.90 [ -4.33, 0.53 ]
Tyni-Lenne 1997 8 -2 (2.35) 8 0.1 (1.8) 0.9 % -2.10 [ -4.15, -0.05 ]
Tyni-Lenne 2001 16 -1.1 (4.24) 8 1.6 (3.45) 0.6 % -2.70 [ -5.87, 0.47 ]
Tyni-Lenne/Gordon 96 7 -0.5 (2.83) 7 0.3 (4.6) 0.4 % -0.80 [ -4.80, 3.20 ]
Wielenga 1999 CHANGE 35 -1.4 (2.95) 32 -0.6 (3.4) 1.2 % -0.80 [ -2.33, 0.73 ]
Subtotal (95% CI) 228 200 10.3 % -1.79 [ -2.33, -1.24 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 9.25, df = 13 (P = 0.75); I2 =0.0%
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 6.45 (P < 0.00001)
7 Mean age > 55 years
Belardinelli 1999 48 -4.2 (1.55) 46 -0.8 (2) 1.6 % -3.40 [ -4.13, -2.67 ]
Coats 1990 10 -3.2 (3.8) 10 -0.8 (3.5) 0.6 % -2.40 [ -5.60, 0.80 ]
Coats 1992 17 -2.4 (4.5) 17 0 (4.3) 0.6 % -2.40 [ -5.36, 0.56 ]
Gottlieb 1999 11 -2.4 (2.8) 14 -0.1 (2.6) 0.9 % -2.30 [ -4.44, -0.16 ]
Maiorana 2000 13 -2.6 (4.6) 13 -0.1 (4.14) 0.5 % -2.50 [ -5.86, 0.86 ]
Oka 2000 18 -0.52 (4.27) 18 0 (3.8) 0.7 % -0.52 [ -3.16, 2.12 ]
Ponikowski 1997 16 -2 (3.8) 13 0.5 (4) 0.7 % -2.50 [ -5.36, 0.36 ]
Pu 2001 9 0.42 (4.1) 7 -0.35 (2.74) 0.5 % 0.77 [ -2.59, 4.13 ]
Quittan 1999 11 -2.6 (3) 12 -0.7 (2.95) 0.8 % -1.90 [ -4.33, 0.53 ]
Tyni-Lenne 1997 8 -2 (2.35) 8 0.1 (1.8) 0.9 % -2.10 [ -4.15, -0.05 ]
Tyni-Lenne 2001 16 -1.1 (4.24) 8 1.6 (3.45) 0.6 % -2.70 [ -5.87, 0.47 ]
Tyni-Lenne/Gordon 96 7 -0.5 (2.83) 7 0.3 (4.6) 0.4 % -0.80 [ -4.80, 3.20 ]
Wielenga 1998 35 -1.44 (3.05) 32 -0.63 (3) 1.2 % -0.81 [ -2.26, 0.64 ]
Wielenga 1999 CHANGE 35 -1.4 (2.95) 32 -0.6 (3.4) 1.2 % -0.80 [ -2.33, 0.73 ]
Willenheimer 1998 22 -0.9 (2.6) 27 0.1 (1.9) 1.3 % -1.00 [ -2.30, 0.30 ]
Subtotal (95% CI) 276 264 12.5 % -1.77 [ -2.50, -1.03 ]
Heterogeneity: Tau2 = 0.79; Chi2 = 25.80, df = 14 (P = 0.03); I2 =46%
Test for overall effect: Z = 4.73 (P < 0.00001)
8 Mean age =/< 55 years
Belardinelli 1995 36 -1.15 (1.36) 19 0.8 (1.54) 1.5 % -1.95 [ -2.77, -1.13 ]
Dubach et al studies 12 -5.7 (4) 13 -1 (4.1) 0.6 % -4.70 [ -7.88, -1.52 ]
Hambrecht 1995 9 -5.8 (3.6) 9 0 (2.7) 0.6 % -5.80 [ -8.74, -2.86 ]
Hambrecht 1998 9 -4.7 (1.17) 9 0.7 (1.48) 1.3 % -5.40 [ -6.63, -4.17 ]
Hambrecht 2000 31 -1.26 (4.3) 33 -0.3 (4.3) 0.9 % -0.96 [ -3.07, 1.15 ]
Jette 1991 18 -1.52 (3.6) 18 0.1 (3.43) 0.8 % -1.62 [ -3.92, 0.68 ]
Keteyian 1996 15 -2.5 (2.3) 14 -0.5 (1.87) 1.2 % -2.00 [ -3.52, -0.48 ]
Kiilavuori 1996 12 -2.4 (7.3) 15 0.1 (5.4) 0.3 % -2.50 [ -7.45, 2.45 ]
Meyer 1996 18 -2.4 (7) 18 -0.4 (0.7) 0.6 % -2.00 [ -5.25, 1.25 ]
Subtotal (95% CI) 160 148 7.9 % -2.95 [ -4.25, -1.64 ]
Heterogeneity: Tau2 = 2.52; Chi2 = 31.81, df = 8 (P = 0.00010); I2 =75%
Test for overall effect: Z = 4.43 (P < 0.00001)
9 Duration of follow up > 16 weeks
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Belardinelli 1995 36 -1.15 (1.36) 19 0.8 (1.54) 1.5 % -1.95 [ -2.77, -1.13 ]
Belardinelli 1999 48 -4.2 (1.55) 46 -0.8 (2) 1.6 % -3.40 [ -4.13, -2.67 ]
Gottlieb 1999 11 -2.4 (2.8) 14 -0.1 (2.6) 0.9 % -2.30 [ -4.44, -0.16 ]
Hambrecht 1995 9 -5.8 (3.6) 9 0 (2.7) 0.6 % -5.80 [ -8.74, -2.86 ]
Hambrecht 1998 9 -4.7 (1.17) 9 0.7 (1.48) 1.3 % -5.40 [ -6.63, -4.17 ]
Hambrecht 2000 31 -1.26 (4.3) 33 -0.3 (4.3) 0.9 % -0.96 [ -3.07, 1.15 ]
Keteyian 1996 15 -2.5 (2.3) 14 -0.5 (1.87) 1.2 % -2.00 [ -3.52, -0.48 ]
Kiilavuori 1996 12 -2.4 (7.3) 15 0.1 (5.4) 0.3 % -2.50 [ -7.45, 2.45 ]
Wielenga 1998 35 -1.44 (3.05) 32 -0.63 (3) 1.2 % -0.81 [ -2.26, 0.64 ]
Subtotal (95% CI) 206 191 9.6 % -2.74 [ -3.83, -1.65 ]
Heterogeneity: Tau2 = 1.88; Chi2 = 39.26, df = 8 (P<0.00001); I2 =80%
Test for overall effect: Z = 4.94 (P < 0.00001)
10 Duration of follow up =/< 16 weeks
Coats 1990 10 -3.2 (3.8) 10 -0.8 (3.5) 0.6 % -2.40 [ -5.60, 0.80 ]
Coats 1992 17 -2.4 (4.5) 17 0 (4.3) 0.6 % -2.40 [ -5.36, 0.56 ]
Dubach et al studies 12 -5.7 (4) 13 -1 (4.1) 0.6 % -4.70 [ -7.88, -1.52 ]
Jette 1991 18 -1.52 (3.6) 18 0.1 (3.43) 0.8 % -1.62 [ -3.92, 0.68 ]
Maiorana 2000 13 -2.6 (4.6) 13 -0.1 (4.14) 0.5 % -2.50 [ -5.86, 0.86 ]
Meyer 1996 18 -2.4 (7) 18 -0.4 (0.7) 0.6 % -2.00 [ -5.25, 1.25 ]
Oka 2000 18 -0.52 (4.27) 18 0 (3.8) 0.7 % -0.52 [ -3.16, 2.12 ]
Ponikowski 1997 16 -2 (3.8) 13 0.5 (4) 0.7 % -2.50 [ -5.36, 0.36 ]
Pu 2001 9 0.42 (4.1) 7 -0.35 (2.74) 0.5 % 0.77 [ -2.59, 4.13 ]
Quittan 1999 11 -2.6 (3) 12 -0.7 (2.95) 0.8 % -1.90 [ -4.33, 0.53 ]
Tyni-Lenne 1997 8 -2 (2.35) 8 0.1 (1.8) 0.9 % -2.10 [ -4.15, -0.05 ]
Tyni-Lenne 2001 16 -1.1 (4.24) 8 1.6 (3.45) 0.6 % -2.70 [ -5.87, 0.47 ]
Tyni-Lenne/Gordon 96 7 -0.5 (2.83) 7 0.3 (4.6) 0.4 % -0.80 [ -4.80, 3.20 ]
Wielenga 1999 CHANGE 35 -1.4 (2.95) 32 -0.6 (3.4) 1.2 % -0.80 [ -2.33, 0.73 ]
Willenheimer 1998 22 -0.9 (2.6) 27 0.1 (1.9) 1.3 % -1.00 [ -2.30, 0.30 ]
Subtotal (95% CI) 230 221 10.8 % -1.55 [ -2.17, -0.94 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 10.19, df = 14 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 4.93 (P < 0.00001)
Total (95% CI) 2154 2037 100.0 % -2.19 [ -2.48, -1.90 ]
Heterogeneity: Tau2 = 1.25; Chi2 = 305.75, df = 117 (P<0.00001); I2 =62%
-10 -5 0 5 10
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(Continued . . . )
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(. . . Continued)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 14.77 (P < 0.00001)
-10 -5 0 5 10
Favours treatment Favours control
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H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 3, 2004
Date Event Description
18 May 2004 New citation required and conclusions have changed Substantive amendment
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